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Once regarded as “byproducts” of aerobic metabolism, the production of 
superoxide/H2O2 is now understood to be a highly specialized and extensively regulated 
process responsible for exerting control over a vast number of thiol-containing proteins, 
collectively referred to as the redox-sensitive proteome.  Although disruptions within this 
process, secondary to elevated peroxide exposure, have been linked to disease, 
delineation of the sources and mechanisms regulating this increased peroxide burden 
remain poorly defined and as such difficult to target using pharmacotherapy.  Herein we 
demonstrate a role for pyruvate dehydrogenase (PDH) as a key source of H2O2 under 
physiological constraints in which respiratory chain-dependent electron leak is 
negligible.  PDH is shown to generate H2O2 as a function of glutathione content, matrix 
metabolic balance, as well as antioxidant reductase activity.  With respect to the latter, 
manipulation of matrix redox buffering reveals a novel mechanism whereby H2O2 
producing NADH-linked dehydrogenases, such as PDH, are functionally linked to the 
ii 
 
redox buffering network within skeletal muscle through the activity of nicotinamide 
nucleotide transhydrogenase (NNT).  These findings highlight the importance of NNT 
and the entire redox buffering system in regulating cytosolic peroxide emission and 
suggest a novel and pivotal role for PDH as a redox-sensitive reporter of matrix redox 
buffering integrity and nutrient status.  
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CHAPTER 1: REVIEW OF THE LITERATURE 
   
Portions of Chapter I adapted from: Fisher-Wellman KH, Neufer PD. Linking 
mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol 
Metab. 2012 Mar;23(3):142-53. (PMID: 22305519) 
Organization and function of the respiratory system 
 
In 1961, Peter Mitchell published a unique hypothesis regarding cellular 
bioenergetic conservation (39), for which he was awarded the Nobel Prize in chemistry 
in 1978.  Termed the “chemiosmotic theory of oxidative phosphorylation” (also known as 
chemiosmosis), at its core is the notion of coupling hydrogen and electron transfer 
through an energy-conserving membrane to the phosphorylation of ADP to form ATP.  
The mitochondrial electron transport system consists of several multi-polypeptide 
protein complexes (I-V) embedded in the inner mitochondrial membrane that receive 
electrons from reducing equivalents (i.e., NADH, FADH2)  generated by 
dehydrogenases (e.g., pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, acyl-
CoA dehydrogenase, etc).  These electrons are transferred through a series of electron 
carriers in the respiratory chain with O2 serving as the final electron acceptor, ultimately 
reducing ½O2 to H2O.  Each of the electron carriers represents a redox couple (i.e., 
species capable of existing in a reduced or oxidized state) with a characteristic 
reduction potential – a measure of the tendency of the oxidized species to accept an 
electron(s).  A negative reduction potential indicates the reduced species has a high 
tendency to donate (lose) an electron(s) (e.g., NADH) and a positive reduction potential 
indicates the oxidized species has a high tendency to accept (gain) an electron(s) (e.g., 
O2).  The electron carriers in the respiratory chain are ordered in such a way that the 
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reduction potentials progressively increase (i.e., become more positive) from one redox 
couple to another.  In three of these complexes (I, III and IV), the difference in reduction 
potential (i.e., release of energy) across successive redox couples is sufficient to drive 
the translocation of protons from the matrix to the inner membrane space.  This creates 
a proton gradient across the inner membrane that is derived from both the concentration 
(∆pH) and the electrical potential (∆ũH+) difference across the membrane.  By 
bioenergetic convention, ∆ũH+ is converted to units of electrical potential (i.e., mV), and 
commonly referred to as the membrane potential (∆Ψ).  Although ∆pH and ∆Ψ together 
comprise the total proton motive force (∆p), ∆Ψ is by far the dominant component and 
often used synonymously with ∆p. The essence of the chemiosmotic theory is that the 
electrical-chemical potential energy created by the generation of ∆p is sufficient to drive 
the synthesis of ATP as protons flow back through the ATP synthase complex into the 
matrix. 
Several features of the respiratory system, some counterintuitive, are essential to 
understanding how cellular energy balance is normally governed and therefore how 
cellular energy surplus may affect the system.  First, similar to an electrical circuit, the 
transport of electrons through the respiratory chain is an inherent property of the system 
– it occurs automatically.  Second, for the most part, electron flow and proton pumping 
are tightly coupled; that is, one does not occur without the other.  The third feature 
requires visualizing the boundaries that govern the system in real time.  Consider 
starting with a de-energized system.  To activate respiration, fuel (i.e., NADH, FADH2) is 
added which automatically initiates electron flow, proton pumping, and O2 consumption.  
However, as ∆Ψ begins to build on the outer surface of the inner membrane, a “back 
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pressure” is created which begins to oppose the pumping of protons, thereby gradually 
slowing electron flow and O2 consumption.  Eventually the point is reached at which the 
force driving the pumping of protons out of the matrix (i.e., the reduction potential span 
from the NAD+/NADH couple to the O2/2H2O couple) is completely counter-balanced by 
the high ∆Ψ.  This creates “static head” equilibrium.  Fortunately, mitochondria never 
reach this state (i.e., we never stop consuming O2) because the mitochondrial inner 
membrane is inherently leaky to protons.  This basal rate of proton conductance 
ensures that ∆Ψ is at some value less than maximum, thereby “allowing” electron flow, 
proton pumping, and O2 consumption to operate at an “idling” rate (known as state 2 
respiration).  If another avenue for protons to flow back into the matrix is created (e.g., 
via ATP synthase catalyzing re-phosphorylation of ADP), then the back pressure (∆Ψ) 
is further reduced and electron flow, proton pumping, and oxygen consumption increase 
accordingly (known as state 3 respiration).  Once all of the ATP is resynthesized, the 
system slows back to the idling rate (known as state 4 respiration)  The critical point is 
that the mitochondrial respiratory system is a “primed engine”, automatically adjusting to 
each change in the rate of proton re-entry into the matrix with a corresponding change 
in electron flow and O2 consumption.  The fourth and final feature should be apparent 
from the first three; the rate at which the respiratory system operates is governed by 
energy demand (“pull”), not energy supply (“push”).  Proton conductance (via leak and 
ATP synthase) dictates the rate of electron flow and therefore the demand for reducing 
equivalents (e.g., NADH and FADH2) which, in turn, regulates the rate of substrate 
uptake and flux through catabolic pathways.     
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How then may an excess of metabolic fuel affect the system?  To address this question 
requires consideration of redox state, which is defined as the product of the reduction 
potential and the reducing capacity (i.e., the concentration of the reduced species) of a 
redox couple.  The higher the concentration of the reduced species, the more reduced 
or “charged” the redox state.  Thus, a provision of excess reducing equivalents due to 
over nutrition will increase the “pressure head” at the entry point of electrons into 
complex I (↑ NADH/NAD+) and/or the Q pool (↑ FADH2/FAD+), in either case elevating 
the redox state and membrane potential of the respiratory system.  Several of the redox 
couples within the electron transport chain transfer single rather than two electrons and 
are therefore susceptible to leaking electrons directly to surrounding O2 to form the free-
radical superoxide (O2• ).  Under state 3 conditions, the redox state of the system is 
below the threshold at which electrons will leak to O2.  However, at or near state 4 
respiration, the respiratory system is in its most reduced state such that the rate at 
which O2•  is produced is extremely sensitive to the redox state of the system, 
increasing exponentially with even small increases in membrane potential (34, 37, 38).  
Fortunately, O2•⁻ is rapidly converted by manganese superoxide dismutase (MnSOD) to 
the two-electron non-radical hydrogen peroxide (H2O2).  H2O2 in turn can be further 
reduced to H2O in the mitochondrial matrix by glutathione (GSH) or the 
thioredoxin/peroxiredoxin systems, or can freely diffuses out of the mitochondria where 
it again is buffered by GSH.  Thus in a resting cell, the mitochondrial respiratory system 
functions as a redox pressure gauge that senses and reflects cellular metabolic 
balance.  When in positive balance, electron leak serves as a release valve, 
accelerating mitochondrial O2•  production and H2O2 emission. 
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Sites of electron leak within mammalian mitochondria 
 
Currently identified sites of electron leak within the respiratory chain include the 
flavin mononucleotide (site IF) and ubiquinone binding site (site IQ) within complex I, the 
quinone at centre “o” within complex III (site IIIQo), the quinone binding site within 
glycerol-3-phosphate dehydrogenase (G3PDC), and electron transferring flavoprotein Q 
oxioreductase (ETFQOR) (6) (Figure 1).  Additional non-respiratory chain sites include 
the matrix dehydrogenase enzyme complexes pyruvate dehydrogenase (PDH) and α-
ketoglutarate dehydrogenase (KGDH), both of which are believed to generate O2• via 
interactions between the dihydrolipoyl transacetylase (E2) and the FAD-containing 
dihydrolipoamide dehydrogenase (E3) components of their respective enzyme 
complexes (53).  With respect to the former, mammalian PDH is comprised of three 
main catalytic components (E1-pyruvate dehydrogenase, E2, E3), which combine to 
form a large (~9.5 MDa) multi-subunit holoenzyme with a stoichiometry of 40:40:20 
(E1:E2:E3) (7).  Maximal PDH/KGDH-stimulated rates of O2• are observed when the 
steady-state ratio of dihydrolipoate (DHLA) to lipoate (LA) within E2 is shifted in favor of 
the reduced form and supply of NAD+ is decreased (i.e., ↑DHLA/LA, ↓NADH/NAD+). 
Under these conditions, it is believed that E3 catalyzes a 1e- oxidation reaction between 
O2 and E2-bound dihydrolipoate, in turn leading to either O2• and/or a thiyl radical (8, 
9). 
Linking mitochondrial bioenergetics to protein function via redox biology 
The production of O2•/H2O2 within biological systems was originally thought to 
exist merely as a deleterious byproduct of aerobic metabolism, that under normal (i.e., 
healthy) conditions were readily scavenged/degraded by the elaborate antioxidant 
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defense machinery.  At any one time point, the actual oxidative burden imposed to the 
system was believed to be dictated by the net balance of these two opposing systems 
(H2O2 production vs. antioxidant buffering).  In line with this notion, the term oxidative 
stress is commonly utilized as a general term to indicate any biological situation in 
which the production of H2O2 exceeds the ameliorating capabilities of the antioxidant 
defense system, potentially resulting in modification/ damage to various 
macromolecules (18).  This oxidative damage has been suggested to play a role in the 
etiology of a myriad of human diseases, as well as the aging process (12).  Although, 
the preponderance of evidence certainly suggests a critical role for these species in ill 
health/disease, specific cause and effect mechanisms have proven difficult to establish.  
Moreover, the use of various antioxidant treatments/interventions in an attempt to curtail 
disease progression and/or slow the aging process has been met with minimal success 
(12).  If oxidative damage mediated by these species are indeed so critical in human 
pathophysiology, and operating under the belief that this damage occurs under 
conditions in which free radical expression exceeds that of defenses, why then would 
exogenous supply of antioxidants not be met with positive outcomes?  One potential 
explanation lies in the continual observation that these prooxidant species are not 
merely byproducts that the system must constantly protect against.   
H2O2 is now widely accepted as a critical signaling molecule within biological 
systems (14, 28).  In fact, the continuous generation of H2O2, at concentrations far 
below those indicative of “oxidative stress”, is believed to be involved in the regulation of 
various redox signaling pathways, referred to as “redox circuits” (Figure 2) (28).  
Cellular redox circuits are analogous to electrical circuits in that they are established by 
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a set of linked oxidation/reduction reactions initiated by a difference in reduction 
potential between two redox couples (i.e., voltage) and propogated as electron flow (i.e., 
electrical current) among successive redox couples with higher reduction potentials. 
The glutathione (2GSH/GSSG) and thioredoxin (TrxRed/TrxOx) redox couples, both of 
which are expressed at high levels and derive their reducing power from 
NADPH/NADP+, serve as the common control nodes of the circuit (i.e., the wiring) and 
the direct link to cysteine (Cys) residues within specific redox-sensitive proteins.  
Electron flux through these couples is thought to be rapid and continuous reflecting the 
rates of reducing (NADPH/NADP+, the “charge” within the circuit) and oxidizing (H2O2 
production, the “dissipation of charge”) inputs.  Under normal circumstances, the 
balance strongly favors reduction of protein Cys and thus an overall reduced cellular 
redox environment.  Of the ~214,000 Cys residues within the proteome, it is estimated 
>20,000 are redox sensitive (i.e., capable of oscillating between a reduced and oxidized 
state as a redox couple) (28).  The activity/function of these redox sensitive proteins is 
dependent upon the redox state of the sulfur atoms within these Cys moieties, thus 
giving rise to the term “sulfur switches” (28).  The sulfur atom within Cys can exist as a 
reduced thiol (-SH) or in a variety of oxidation states, including as a thiolate anion (-S-), 
sulfenate (-SO-), disulfide (-S-S) sulfinate (-SO2-), or sulfonate (-SO3-) (28).  Each of 
these redox-sensitive switches has a characteristic reduction potential, or sensitivity to 
the redox circuit, that reflects in large part the degree to which each redox sensitive Cys 
within the protein is spatially and kinetically insulated from the circuit.  Alterations in the 
redox state of these “sulfur switches” induces a variety of effects, including changes in 
protein conformation, enzyme activity, transporter activity, ligand-receptor binding, 
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protein-protein interaction, protein trafficking, protein degradation, and transcriptional 
binding to DNA (28). 
Nicotinamide nucleotide transhydrogenase (NNT) as a principle source of 
reducing power  
Much of the literature thus far has focused on the potential consequence of 
elevated peroxide production in terms of contributing to human disease.  However; 
based on the current working model of the organization/structural characteristics of 
redox signaling networks, protein redox status is primarily dictated not by H2O2 
production, but rater by supply of reducing power (i.e., NADPH).  That is, alterations in 
cellular redox in the context of a redox-mediated signaling event could just as easily be 
propagated via a reduction in NADPH supply as they could by an increase in H2O2 
production.  This concept represents a potential paradigm shift within the field in which 
investigative emphasis is directed not only towards uncovering the specific proteins 
responsible for H2O2 generation, but also to those tasked with the maintenance of 
cellular reducing power (i.e., NADPH producing enzymes).  
Cellular sources of NADPH include glucose-6-phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase within the pentose phosphate pathway, as well the 
mitochondrial enzymes NADP-linked isocitrate dehydrogenase, decarboxylating malate 
dehydrogenase (malic enzyme; also present in the cytosol) and nicotinamide nucleotide 
transhydrogenase (NNT) (46, 47).  NNT is particularly interesting in that it is a proton-
translocating enzyme that utilizes the electrochemical proton motive force (∆p) 
generated by the respiratory complexes to drive the thermodynamically unfavorable 
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reduction of NADP+ from NADH (21).  Approximately 50% of mitochondrial NADPH is 
eliminated in the presence of an uncoupler, thus suggesting a significant contribution of 
NNT to matrix NADPH supply (46).  As expected, knockout of NNT in Caenorhabditis 
elegans (5), as well as PC12 cells (60) has indeed been shown to impair cellular redox 
homeostasis (oxidative shift in the glutathione pool), as well as increase sensitivity to 
peroxide exposure, and alter energy metabolism (reduced respiration and levels of 
ATP).   
Role of NNT in controlling insulin secretion: Story of the C57BL/6J line 
NNT gained considerable attention within the field of diabetes research when 
mutations within the NNT gene were successfully linked to the glucose intolerant 
phenotype of the C57BL/6J mouse strain (16, 57).  C57BL/6J mice are one of the most 
routinely employed animal models of glucose intolerance, due primarily to their 
increased susceptibility to develop insulin resistance and overt type II diabetes when fed 
a high fat diet (HFD) (30, 55, 56).  Interestingly, when fed a HFD, these mice are also 
characterized by an increase propensity for weight gain, despite similar levels of nutrient 
intake (54).  In an elegant series of experiments conducted by Toye et al., (57) the 
phenotype C57BL/6J strain was mapped to a naturally occurring in-frame five exon 
deletion within the NNT gene, which removes exons 7-11 of the mature peptide, 
effectively creating an NNT whole body knockout (16, 23).  This mutation is believed to 
have occurred sometime between 1970 and 1984 and is apparently specific to the pure 
C57BL/6J strain produced only by the Jackson Laboratory 
(http://jaxmice.jax.org/strain/000664.html).  Follow up experiments in which functional 
NNT was reintroduced via transgenic expression successfully rescued the impaired 
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insulin secretion and glucose intolerant phenotype of the C57BL/6J mice.  A role for 
NNT in controlling pancreatic insulin secretion was subsequently demonstrated using 
siRNA directed at NNT within an insulin secreting cell line (15).  With regards to the 
mechanism of action, loss of NNT is believed to elevate “oxidative stress” within the 
beta cell in response to glucose, thereby lowering the ATP: ADP ratio and delaying 
closure of the KATP channel (15, 46).  While much of the literature related to the 
C57BL/6J strain has focused on the impact of NNT on insulin secretion, very little is 
currently known about the effects of NNT loss on other tissues, specifically within insulin 
sensitive peripheral tissues such as skeletal muscle. 
Central Hypothesis 
 
The goal of this dissertation was to determine if the pyruvate dehydrogenase 
complex is a source of H2O2 production and therefore a component of the matrix redox 
network.   The overriding hypothesis was that PDH and perhaps other NADH-linked 
dehydrogenases exist as  continual sources of H2O2 necessary to establish various 
redox signaling networks within the matrix.  In Chapter II we reveal PDH as a principle 
source of H2O2 within skeletal muscle under physiological constraints.  In Chapter III, we 
demonstrate a role for NNT in controlling mitochondrial peroxide emission within 
skeletal muscle, as well as whole body energy metabolism. Under normal conditions, 
H2O2 generated by PDH was efficiently scavenged by the elaborate redox buffering 
systems present, all of which depend on continual NADPH generation for reducing 
power.  However, loss of redox buffering integrity, either through depletions in cellular 
glutathione and/or NADPH supply, led to a dramatically accelerated rate of PDH-derived 
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H2O2 production, altering whole cell redox status and potentially contributing to disease.   
These data shed valuable insight related to the role of both PDH and NNT in controlling 
matrix redox status and whole body energy metabolism.  Moreover, we hypothesize that 
the identified functional link between PDH-derived H2O2 production and NNT activity 
may have far reaching implications related to the glucose intolerant phenotype of the 
C57BL/6J strain, as well as the development of diet-induced insulin resistance.      
Figure 1. Sites of electron leak within mammalian mitochondria. In mammalian 
mitochondria, currently identified sites of electron leak/superoxide formation in the 
electron transport system (ETS) include the flavin mononucleotide  and ubiquinone 
binding site within complex I (I), the quinone at centre “o” within complex III (III), the 
quinone binding site within glycerol-3-phosphate dehydrogenase (G3PDH), and the 
electron transferring flavoprotein Q oxioreductase (ETF-QO).  Additional non-respiratory 
system sources include the matrix soluble pyruvate (PDH) and alpha-ketoglutarate 
(KGDH) dehydrogenase complexes.  
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Figure 2. Simplified model of redox circuitry.  Theoretical Eh values are shown in 
blue for the 2GSH/GSSG, Trx2SH/TrxSS, and NADPH/NADP+ redox couples, as well as 
their protein target. Electrons flow through the circuit from the NADPH/NADP+ couple to 
thiol (SH) moieties within exposed Cys. The overall driving force for reduction is 
determined by the mV differences in Eh between NADPH/NADP+ and the redox 
sensitive Cys-containing proteins (e.g., ∆Eh = -500 mV). The red text indicates the 
effects of a transient increase in mitochondrial H2O2 emission in the context of a redox 
mediated signaling event. Under these conditions, an oxidative shift in the redox 
environment (depicted as a positive shift in each couple’s Eh), would reduce the overall 
driving force for the reduction of exposed Cys residues within the target protein (∆Eh = -
300 mV), thereby altering the redox state of the protein in favor of its oxidized form (e.g., 
either 2SO- or SS) and leading to a cellular response.  These responses are thought to 
function as a means of rheostat regulation rather than as a simple “on/off” mechanism.  
The blue/red bar on the left labeled “E” represents the intracellular redox environment. 
GR, glutathione reductase; TR, thioredoxin reductase; Gpx, glutathione peroxidase; Prx, 
peroxiredoxin. 
 
  
CHAPTER 2: AN OXIDATIVE SHIFT IN MITOCHONDRIAL REDOX REVEALS 
PYRUVATE DEHYDROGENASE AS A MAJOR H2O2 EMITTING SOURCE 
  
 
Abstract 
Once regarded as “byproducts” of aerobic metabolism, the production of 
superoxide/H2O2 is now understood to be a highly specialized and extensively regulated 
process responsible for exerting control over a vast number of thiol-containing proteins, 
collectively referred to as the redox-sensitive proteome.  Although disruptions within this 
process, secondary to elevated peroxide exposure, have been linked to disease, 
delineation of the sources and mechanisms regulating this increased peroxide burden 
remain poorly defined and as such difficult to target using pharmacotherapy.  Here we 
demonstrate a role for pyruvate dehydrogenase (PDH) as a key source of H2O2 under 
physiological constraints in which respiratory chain-dependent electron leak is 
negligible.  PDH is shown to generate H2O2 as a function of glutathione content, 
antioxidant reductase activity, as well as matrix metabolic balance.  These findings 
suggest a novel and pivotal role for PDH as a redox-sensitive reporter of matrix redox 
buffering integrity and nutrient status.  
Highlights 
•Matrix glutathione depletion reveals PDH as a major source of H2O2 production 
•H2O2 production by PDH depends on the redox state of its E2-bound lipoyl groups  
•NNT deletion reveals a functional link between PDH and the redox buffering 
networks 
•PDH is a continual source of H2O2 even under maximal ADP-stimulating conditions 
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Introduction 
Numerous pathological conditions ranging from cancer to diabetes are 
associated with elevated reactive oxygen species (59).  Specific cause and effect 
relationships however have proven difficult to establish due to the limited, albeit ever-
improving, mechanistic understanding of redox-mediated processes in vivo.  At present, 
the intracellular redox environment is envisaged as a network of interconnected redox 
couples which terminally distribute electrons to the estimated 22,000 redox-sensitive 
thiols throughout the proteome (13, 33).  Disequilibrium between redox couples (i.e., 
reduction potentials), and thus electron flow, is made possible by continuous input into 
the reductive (NADPH) and oxidative (O2, H2O2) arms of the system, thus giving rise to 
the term “redox circuits” (29).  Mitochondria play a central role in this system by 
providing both a major source of the reductive power (e.g., NADPH) as well as the 
effective counterbalance (e.g., H2O2) that dissipates and thus regulates the charge.  In 
fact, it is the regulation of flux through the redox circuitry that is thought to be the 
mechanism by which H2O2 serves as a secondary messenger within biological systems 
(1, 28).  Identification of the primary sources of H2O2, as well as the physiological 
conditions regulating its production rate, is therefore paramount to deciphering the 
underlying mechanisms responsible for the ever-expanding list of diseases with a 
redox-mediated etiological component. 
In mammalian mitochondria, currently identified sites of electron leak/superoxide 
formation in the electron transport system (ETS) include the flavin mononucleotide  and 
ubiquinone binding site within complex I, the quinone at centre “o” within complex III, the 
quinone binding site within glycerol-3-phosphate dehydrogenase, and the electron 
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transferring flavoprotein Q oxioreductase (6).  Superoxide production is membrane 
potential (∆Ψ)-dependent, meaning that electron leak accelerates dramatically when the 
reducing pressure within the ETS, and thus ∆Ψ, increases (i.e., becomes more 
negative) due to elevated reducing equivalent supply (i.e., NADH/NAD+, FADH2/FAD+) 
relative to demand.  Thus, the ETS functions as a gauge of cellular energy balance, 
accelerating electron leak and H2O2 emission when energy supply exceeds demand (2, 
22)).  H2O2 in turn is dismutated to H2O by reduced glutathione and thioredoxin, both of 
which are critical to generating and maintaining the reduction of protein thiols (48, 61).  
Thus in effect, H2O2 dissipates the charge distributed throughout the proteome and is 
therefore thought to be critical to the regulation of various cell processes (29), including 
insulin sensitivity (13). 
In addition to the ETS, several non-respiratory chain sites of superoxide 
production have been identified including the matrix dehydrogenase enzyme complexes 
pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (αKGDH), both of 
which are believed to generate H2O2 via interactions between the dihydrolipoyl 
transacetylase (E2) and the FAD-containing dihydrolipoamide dehydrogenase (E3) 
components of their respective enzyme complexes (53).  However, absolute rates of 
H2O2 production by PDH and αKGDH are very low, and thus the extent to which either 
enzyme contributes to H2O2 production in a physiological context has not been clear (6).  
While investigating the potential influence of redox state on H2O2 production at different 
sites, we were surprised to find that pyruvate-supported H2O2 production by PDH is 
remarkably sensitive to mitochondrial GSH depletion, generating rates of H2O2 emission 
far greater than any other site/substrate combination tested.  Subsequent experiments 
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conducted with isolated enzyme, permeabilized mitochondria, and permeabilized 
skeletal muscle fiber bundles from multiple species reveal a novel regulatory network 
between the PDH complex and the mitochondrial redox environment, the implications of 
which establish PDH as a critical control node within the intracellular redox network 
reporting on both the nutrient status and redox balance present within the mitochondrial 
matrix. 
 
Results 
Site-specific H2O2 emission: Effects of mitochondrial uncoupling and GSH 
depletion. 
To directly compare rates of electron leak from known sites within mitochondria, 
H2O2 emission was monitored in mouse permeabilized skeletal muscle fiber bundles 
under a variety of substrate combinations.  As expected (3, 52), succinate, which feeds 
electrons directly into the Q-pool and induces reverse electron flow back into complex I, 
generated H2O2 emission rates higher than all other substrate combinations tested.  
Surprisingly however, pyruvate alone (i.e., no malate) also generated a substantial rate 
of H2O2 emission (Figure 3A).  These experiments were carried out under non-ADP-
stimulated conditions (i.e., state 4) which favors ETS-supported H2O2 emission (e.g., 
complexes I and III) due to high membrane potential across the mitochondrial inner 
membrane.  As expected, addition of the chemical uncoupler trifluorocarbonylcyanide 
phenylhydrazone (FCCP), which accelerates proton conductance and lowers 
membrane potential, eliminated ETS-derived H2O2 emission (e.g., glutamate/malate and 
succinate, Figures 3B & 3C).  In contrast, FCCP increased H2O2 emission in the 
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presence of α-ketoglutarate, glycerol-3-phosphate and pyruvate (compare Figure 3C to 
3A), suggesting that at least a portion of mitochondrial H2O2 production/emission is 
insensitive to membrane potential and generated by the dehydrogenases themselves.  
To determine the potential sensitivity of H2O2 emission to an oxidative shift in the 
mitochondrial redox environment, permeabilized fiber bundles were pre-treated with the 
glutathione (GSH)-depleting agent 1-chloro-2,4-dinitrobenzene (CDNB).  Catalyzed by 
glutathione S-transferase, CDNB forms an irreversible conjugate with GSH, resulting in 
a gradual depletion of GSH (19, 58).  Compared to GSH-replete fibers, partial depletion 
(~75%) of GSH did not significantly increase H2O2 emission when fibers were energized 
with glutamate/malate, palmitoyl-L-carnitine, α-ketoglutarate, glycerol-3-phosphate, or 
succinate (Figure 3F).  In stark contrast, when respiration was supported solely by 
pyruvate, H2O2 emission rate increased by more than 20-fold (13.2 ± 1.4 (Fig 3A) vs 
281.2 ± 26.8 (Fig 3F) pmol/min/mg dry wt).  These rates were higher than all other 
substrate combinations, including succinate (Figure 3E), and occurred in the absence of 
any difference in pyruvate-supported O2 consumption or NADH production 
(Supplemental Figures 1A & 1B).   
 
Pyruvate-supported JH2O2 shows striking sensitivity to GSH depletion across 
species. 
To determine if pyruvate-supported H2O2 emission is responsive to more 
physiological declines in GSH, rates of H2O2 emission were assessed in fibers pre-
treated with varying concentrations of CDNB.  As little as ~6% depletion in GSH 
generated a significant increase in pyruvate-supported H2O2 emission, with values rising 
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exponentially as GSH levels continued to fall (Figure 3G).  This striking sensitivity to 
GSH depletion was also evident in permeabilized skeletal muscle fiber bundles 
prepared from Sprague-Dawley rats (Figure 3H) and human subjects (Figure 3I).  
Interestingly, higher concentrations of CDNB were required in rat and human fibers to 
induce a comparable level of GSH depletion as that seen in mice, perhaps reflecting 
inter-species differences in total GSH content and/or glutathione-S-transferase 
expression/activity. These findings reveal PDH as a potential major site of H2O2 
production that is extremely sensitive to the mitochondrial redox buffering network.    
 
PDH generates H2O2 directly via interactions between the E2 and E3 domains. 
Mammalian PDH is comprised of three main catalytic components (E1, pyruvate 
dehydrogenase; E2, dihydrolipoyl transacetylase; E3, FAD-containing dihydrolipoyl 
dehydrogenase), which combine to form a large (~9.5 MDa) multi-subunit holoenzyme 
with a stoichiometry of 40:40:20 (E1:E2:E3) (7).  To investigate the mechanisms 
regulating H2O2 production in relation to catalytic flux (Figure 4A), experiments were 
carried out using isolated enzyme.  PDH generated substantial rates of H2O2 in both the 
forward (i.e., pyruvate as substrate, Figure 4B) and reverse (i.e., NADH as substrate, 
Figure 4C) directions.  It should be noted that NADH concentrations in excess of 10 µM 
were found to interfere with the Amplex Ultra Red/HRP detection system (Supplemental 
Figure 3D).  Inclusion of N-ethylmaleimide (NEM), an inhibitor of E2 (9), eliminated 
pyruvate-supported H2O2 production (Figure 4D & 4E).  NEM reacts with reduced thiols 
to form a covalent thioether bond, suggesting that forward electron flux through the 
sulfhydryls of E2 is required to induce electron leak from the PDH complex.  
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Subsequent addition of NADH elicited a partial increase in H2O2 production, suggesting 
electron leak from the E3 component.  In separate experiments, inclusion of the 
irreversible flavoprotein inhibitor diphenyliodonium chloride to block E3 generated a 
partial increase in H2O2 production with pyruvate as substrate.  Inhibition of both E2 and 
E3 completely eliminated H2O2 production with either pyruvate or NADH as substrate.  
These findings suggest that both the E2 and E3 components contribute to H2O2 
production by the PDH complex. 
Exogenous superoxide dismutase (SOD) was included in the preceding 
experiments to ensure superoxide produced by the PDH complex was converted to 
H2O2.  Surprisingly, omission of SOD did not affect pyruvate-supported H2O2 production 
(Figure 4F) whereas inclusion of catalase eliminated the signal (Figure 4G), suggesting 
the PDH complex is producing H2O2 directly.  This is not without precedent as certain 
isoforms of NADPH oxidase (36) and xanthine oxidase (32) have also been shown to 
generate H2O2 directly.    
 
Isolated PDH generates H2O2 primarily as a function E2 “reducing pressure”. 
Reducing pressure within the E2 component of PDH is determined by the redox 
state of its bound lipoyl groups.  These lipoyl moieties oscillate between reduced 
dihydrolipoate (DHLA) and oxidized lipoate (LA) during the course of enzymatic 
turnover.  Reduction to DHLA is determined by the rate of pyruvate decarboxylation at 
E1 in combination with the acetyl transferase activity of E2.  Reoxidation of DHLA 
following acetyl-CoA release is mediated by the FAD-containing dehydrogenase 
component (E3) of the PDH complex via an NAD+-dependent mechanism (Figure 4A).  
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It was therefore hypothesized that PDH-supported H2O2 may be dependent on the ratio 
of DHLA/LA, thus generating a maximal rate of H2O2 when pyruvate and CoA are 
saturating in the absence of NAD+.  To test this hypothesis, PDH-supported JH2O2 was 
measured in response to increasing concentrations of pyruvate either in the absence 
(Figure 5A) or presence (Figure 5B) of NAD+.  As anticipated, NAD+ decreased the 
H2O2 Vmax by ~50% and increased the pseudo Km ([pyruvate] generating half H2O2 Vmax) 
by greater than 60-fold compared to the no NAD+ condition.  These data imply that an 
inability of E3 to regenerate LA following reduction dramatically increases the sensitivity 
of the complex to pyruvate with respect to generation of H2O2.  To further assess the 
influence of NAD+, PDH-mediated H2O2 production was continuously monitored while 
titrating NAD+ and holding the pyruvate concentration constant (1 mM).  NAD+ 
decreased pyruvate-supported JH2O2 in a dose-dependent fashion with an IC50 of 
approximately ~3 µM (Figure 5C), confirming the dependence of PDH on NAD+ as an 
electron acceptor and providing further evidence of the direct influence of reducing 
pressure on PDH-mediated H2O2 production.   
Under physiological conditions, the ratio of NADH/NAD+ varies as a function of 
metabolic balance. To assess the influence of dynamic fluctuations in NADH/NAD+ on 
PDH-mediated H2O2 generation, pyruvate-supported JNADH and JH2O2 were 
monitored in parallel under identical substrate conditions.  The starting NAD+ 
concentration for these assays was 50 µM (~Km for JNADH; data not shown).  Upon 
addition of pyruvate (1 mM), NAD+ was rapidly converted to NADH (Figure 5D blue 
trace), gradually leveling off after ~10 min at a maximum concentration of ~28 µM and a 
ratio of NADH/NAD+ slightly >1.  By contrast, the rate of H2O2 production by PDH 
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appeared to increase in direct proportion to the rise in NADH (Figure 5D, red trace).  
When calculated [H2O2]and [NADH] were converted to point by point production rates, 
the flux derivations were near mirror images of one another (Figure 5E).  The addition of 
oxaloacetate (5 mM) following this initial 10 minute period led to non-enzymatic 
conversion of oxaloacetate to malate at the expense of NADH, effectively regenerating 
NAD+ and drastically decreasing JH2O2.  Interestingly, the rate of H2O2 production in the 
presence of oxaloacetate was similar to that observed during the first 30 seconds 
following pyruvate addition prior to any substantial elevations in NADH (Figure 5F); 
again consistent with the notion that NAD+-mediated re-oxidation of DHLA is a critical 
determinant of PDH-mediated H2O2 production.   
Although the availability of NAD+ is critical to the re-oxidation of the E2 
component, a majority of flux control through the PDH complex is thought to be exerted 
by phosphorylation of the E1 component which inactivates the enzyme (26).  Incubation 
of isolated PDH with recombinant pyruvate dehydrogenase kinase 4 (PDK4), the most 
active PDK isoenzyme in skeletal muscle, as expected elicited a decrease in NADH 
production (Figure 5G), indicative of reduced flux through the complex.  PDK4 also 
induced a parallel decrease in H2O2 production, supporting the concept that the E1-
catalyzed reduction of E2 bound lipoate is necessary for H2O2 generation.  To further 
examine the influence of flux control through PDH on H2O2 production, permeabilized 
skeletal muscle fiber bundles were prepared from wildtype and PDK4-/- mice (27).  As 
expected, pyruvate-supported JO2 consumption was elevated under state 4 conditions 
in fibers from PDK4-/- compared with wildtype mice (Figure 5H) and was matched by a 
nearly identical increase in JH2O2 production (Figure 5I).  Taken together, these data 
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suggest that the rate of H2O2 generation by the PDH complex reflects the reducing 
pressure within the E2 component of the complex which is determined, at least in part, 
by the E1 catalytic flux rate relative to the ratio of NADH/NAD+.     
 
Carnitine elevates pyruvate-supported O2 flux/NADH production and lowers H2O2 
emission by up-regulation of redox buffering.  
Flux through the PDH complex is also subject to direct allosteric inhibition by 
accumulation of acetyl-CoA, the product of the E2 reaction.  Acetyl-CoA accumulates in 
the mitochondrial matrix when entry into the TCA cycle is limited by the availability of 
anaplerotic substrates (e.g., oxaloacetate) for the citrate synthase reaction.  In striated 
muscle, the accumulation of acetyl-CoA is counterbalanced by the activity of carnitine 
acetyltransferase (CrAT), a mitochondrial enzyme that converts excess acetyl-CoA to 
membrane permeable acetylcarnitine esters which may then efflux out of the organelle 
and cell (40).  To investigate how flux through PDH may be integrated with flux through 
other metabolic pathways to regulate JH2O2 production by PDH, a series of experiments 
were performed using permeabilized skeletal muscle fiber bundles.  In agreement with 
previous findings (40), addition of carnitine to permeabilized fibers energized with 
pyruvate alone markedly increased JO2 consumption (Figure 6A) and JNADH 
production (Figure 6B), consistent with a CrAT-catalyzed relief of acetyl-CoA-mediated 
inhibition of PDH.  Based on the increase in JH2O2 observed when flux through PDH 
was increased by the ablation of PDK4 (Figure 5I), it was anticipated JH2O2 would also 
increase in response to a carnitine-mediated increase in flux through PDH.  Surprisingly 
however, addition of carnitine decreased pyruvate-supported mitochondrial JH2O2 
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emission, a response that was particularly evident in fibers pretreated with increasing 
concentrations of CDNB to reduce matrix GSH (Figure 6C).  In other words, the 
extremely high PDH-mediated JH2O2 evident in GSH-depleted fibers (e.g., Figure 3) 
was markedly attenuated when flux through PDH was increased by addition of carnitine.  
This suggested that the net rate of H2O2 generation by PDH does not simply reflect a 
balance between flux through the complex and buffering of the H2O2 by GSH, but may 
involve a more complex relationship with the matrix redox buffering system.  To test this 
possibility, experiments were repeated in the presence of inhibitors of both glutathione 
reductase (bis-chloroethylnitrosourea, BCNU) and thioredoxin reductase (auranofin, AF) 
without depleting matrix GSH.  Under these conditions, the ability of carnitine to 
suppress PDH-mediated JH2O2 emission (i.e., pyruvate sole substrate) was eliminated; 
in fact, addition of carnitine generated a marked increase, not a decrease, in pyruvate-
supported JH2O2 emission (Figure 6D & 6E).  Of note, even prior to the addition of 
carnitine, pyruvate-supported JH2O2 emission was ~2-fold higher in BCNU/AF treated 
versus non-treated fibers, reflecting the absence of input from the redox buffering 
network.  This apparent dependence on the matrix redox buffering system was 
confirmed in a similar series of experiments performed on permeabilized fibers from 
wildtype and muscle-specific CrAT null mice (CrATM-/-).  Addition of carnitine increased 
flux through PDH (i.e., increased state 4 JO2, Supplemental Figure 2A) and decreased 
H2O2 emission in permeabilized fibers from wildtype mice with an intact redox buffering 
system (Figure 6F open bars, similar to 6C).  However, when both arms of the matrix 
redox buffering system were blocked (+BCNU/AF), addition of carnitine increased 
JH2O2 emission by PDH (Figure 6G open bars, similar to 6E).  In the absence of CrAT 
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(i.e., permeabilized fibers from CrATM-/-), the ability of carnitine to reduce PDH-mediated 
JH2O2 emission with an intact buffering system (Figure 6F), and by contrast to increase 
JH2O2 emission when redox buffering was inhibited (Figure 6G), were both lost, 
confirming the effects of carnitine were mediated by CrAT activity. Finally, when malate 
was used in place of carnitine to facilitate entry of acetyl-CoA into the TCA cycle and 
thereby accelerate PDH flux (i.e., increase in state 4 JO2, Supplemental Figure 2B), 
PDH-mediated JH2O2 emission decreased when the redox buffering system was intact, 
but increased dramatically when the redox buffering system was blocked (Figure 6H-I).   
Collectively, these findings suggest that flux through the PDH complex is coupled 
to the matrix redox buffering system, the integration of which appears to be playing a 
major role in determining the net rate of H2O2 generation by PDH.  It is important to note 
that the difference in pyruvate-supported JO2 observed in permeabilized fibers from 
PDK4-/- versus wildtype mice (Figure 5H) was only a fraction of the increase in JO2 
observed in permeabilized fibers from wildtype mice in the presence of carnitine or 
malate (Supplemental Figures 2A and 2B).  This indicates that with pyruvate as the sole 
substrate, the rate of NADH production was insufficient to support state 4 respiration in 
permeabilized fibers from PDK4-/- mice, most likely due to allosteric inhibition of PDH by 
acetyl-CoA.  However, when acetyl-CoA accumulation was prevented by addition of 
carnitine (acetyl-CoA conversion to acetylcarnitine via CrAT) or malate (acetyl-CoA 
entry into the TCA cycle), the rate of NADH production by PDH was fully sufficient to 
support state 4 respiration.  This led us to speculate that JNADH generation may be a 
key factor coupling PDH to the matrix redox buffering systems and thus the control of 
H2O2 generation by the PDH complex.  
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Functional nicotinamide nucleotide transhydrogenase is required for carnitine-
induced depressions in PDH-supported JH2O2. 
 The mitochondrial glutathione and thioredoxin redox buffering systems derive 
their reducing potential from NADPH.  The principle source of NADPH in the matrix is 
nicotinamide nucleotide transhydrogenase (NNT), an inner mitochondrial trans-
membrane protein that utilizes the proton gradient across the inner mitochondrial 
membrane to drive the otherwise thermodynamically unfavorable regeneration of 
NADPH from NADH (25, 43).  Thus, NADH is both a substrate for NNT and a source of 
fuel for the ETS to generate the membrane potential needed by NNT.  It was therefore 
reasoned that the rate of NADH generation may be critical to the rate at which NADPH 
regeneration can be maintained by NNT, and therefore the rate at which the glutathione 
and thioredoxin reductase reactions can be supported to regenerate GSH and buffer 
H2O2 produced by PDH.  To test this hypothesis, membrane potential was lowered by 
addition of FCCP to permeabilized fiber bundles respiring on pyruvate alone.  In 
contrast to the decrease in pyruvate-supported H2O2 emission observed upon addition 
of carnitine under state 4 respiratory conditions (i.e., when membrane potential is high; 
Figure 6C and 6F), addition of carnitine during uncoupled respiration (+FCCP) induced 
higher rates of H2O2 emission (Figure 7A), providing at least indirect evidence that loss 
of membrane potential limits NNT activity and buffering of  PDH-mediated JH2O2.  To 
directly determine the dependence of PDH-mediated JH2O2 on NNT activity, pyruvate-
only-supported JH2O2 emission was measured in permeabilized fiber bundles from 
C57BL/6J mice, which lack functional NNT (16, 57), and compared with permeabilized 
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fibers from C57BL/6N mice, which express functional NNT.  Pyruvate only supported 
JH2O2 emission was higher in permeabilized fibers from C57BL/6J mice and addition of 
carnitine sharply increased JH2O2 emission (Figure 7B & 7C), similar to the response 
observed when matrix redox buffering was compromised by inhibition of both 
glutathione and thioredoxin reductase (Figure 6E).  These findings indicate that H2O2 
production by PDH is a function of the coupling between PDH-mediated JNADH and 
NNT-mediated JNADPH.  While NNT accounts for ~50% of matrix NADPH formation 
(46), other potential sources include the NADP+-dependent isocitrate dehydrogenase 2 
and NADP+-dependent malate dehydrogenase (i.e., malic enzyme).  Indeed, addition of 
malate completely abrogated the carnitine-induced increase in JH2O2 in permeabilized 
fibers from C57BL/6J mice (Figure 7D), suggesting that provision of a source of NADPH 
alternative to NNT was able to restore the coupling between the matrix redox buffering 
systems and regulation of PDH-mediated H2O2 production.  That the effect of malate 
was mediated by NADPH was confirmed by addition of BCNU and AF to block matrix 
redox buffering, which completely eliminated the rescue effect of malate (Figure 7D, 
+BCNU/AF).   
 
Manipulation of matrix redox buffering reveals PDH as the principle source of 
H2O2 during maximal state 3 respiration. 
 The C57BL/6J mice in combination with carnitine provide a unique model 
whereby H2O2 emission derived specifically from the PDH complex can be assessed in 
the absence of redox buffering, as well as at varying levels of reactivity.  Using this 
approach it was possible to design experiments to determine the impact of NADH/NAD+ 
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on pyruvate-supported H2O2 emission under physiological constraints (i.e., ADP-
stimulated conditions in the absence of respiratory inhibitors).  As anticipated based on 
the isolated enzyme experiments (Figure 5E), the addition of ADP to permeabilized 
fibers prepared from C57BL/6J mice energized with pyruvate and carnitine led to a 
dose-dependent decrease in H2O2 emission (Figure 8A), presumably reflecting the 
consequence of a progressive decrease (i.e., oxidation) in NADH/NAD+ ratio (Figure 5C 
& 5E).  It is important to point out that even under maximal ADP stimulated conditions 
when H2O2 production by the ETS is negligible (i.e., <1 pmol/min/mg dry wt, analogous 
to +FCCP for GM and S in Fig 3B and 3C), PDH is still capable of producing substantial 
rates of H2O2 (~22 pmol/min/mg dry wt). 
 Lastly, to estimate the potential contribution of H2O2 production by PDH relative 
to the ETS in a physiological context, a series of JO2 production and JH2O2 emission 
assays were carried out in permeabilized fibers from C57BL/6N mice under non-ADP 
(state 4) and steady-state ADP-stimulated conditions using a respiratory clamp system.  
To focus only on H2O2 production (i.e., no matrix redox buffering), all JO2 and JH2O2 
experiments were carried out in the presence of BCNU and AF.  Under state 4 
conditions, H2O2 produced/O2 consumed was highest for permeabilized fibers 
supported by succinate alone, but that rate dropped to near zero upon transition to 
maximal state 3 conditions (Figure 8B).  By contrast, the rate of H2O2 produced/O2 
consumed was elevated even under state 3 conditions when permeabilized fibers were 
supported by pyruvate/carnitine and, to a lesser extent, glutmate/malate (the latter likely 
reflecting production from glutamate dehydrogenase and/or αKGDH).  Taken together, 
these findings suggest that matrix dehydrogenases are likely a constant source of H2O2 
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production in mitochondria, the potential being greatest for PDH due to its sensitivity to 
the redox buffering system. 
 
Discussion 
Establishment and maintenance of cellular redox circuitry is dependent upon 
continual generation (NADPH) and dissipation (H2O2) of reducing potential within the 
mitochondrial and cytosolic compartments.  The results contained herein reveal the 
PDH complex as a pivotal sensor and regulator within the redox circuitry system that 
integrates with the matrix redox buffering system and metabolic state of the cell to 
regulate H2O2 production.  In this context, there are three main findings from the present 
study.  First, PDH was shown to generate H2O2 directly at a rate responsive to the 
metabolic balance of the cell (i.e., NADH/NAD+), to the downstream flux rate of the 
reaction product (i.e., acetyl-CoA), and, perhaps most striking, to the integrity of the 
redox buffering system.  The dramatic sensitivity of PDH to declines in matrix GSH 
content was particularly interesting in that the effect was unique to PDH.  Moreover, 
pyruvate-supported H2O2 emission gradually increased to rates exceeding all other 
substrate combinations.  Second, the rate of H2O2 emission from PDH was found to be 
under the direct influence of the redox buffering network through an NNT-mediated self-
quenching mechanism.  These findings reveal the dynamic interactions between NADH-
linked dehydrogenases and the matrix redox buffering network, firmly establishing the 
importance of NNT in the maintenance of matrix reducing power (i.e., NADPH supply) 
and control of peroxide emission.  Lastly, manipulation of the redox buffering network 
unveiled PDH, and to a lesser extent other matrix soluble dehydrogenases, as 
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significant and constant sources of H2O2 production even under ADP-stimulating 
conditions.  To our knowledge, this is the first evidence of mitochondrial H2O2 
production under state 3 conditions, suggesting that the matrix dehydrogenases 
contribute substantially to the overall peroxide burden.  Collectively, these findings 
reveal an extremely sensitive and exquisitely balanced network between the PDH 
complex and the redox buffering system that both senses and responds to reducing 
pressure in accordance with the overall state of the mitochondrial redox environment.  
This supports a novel paradigm, exemplified by the PDH complex, in which control of 
the redox environment is exerted and dominated by the redox buffering network rather 
than simply production of reactive oxygen species. 
In the present investigation, PDH was found to generate H2O2 as a function of 
NADH/NAD+ in a manner that was independent of mitochondrial membrane potential.  
The dependence/independence of H2O2 production on membrane potential is difficult to 
determine in an intact system, due in part to the lack of a specific inhibitor of NADH 
oxidation at complex I.  Use of any ETS inhibitor downstream of complex I (e.g., 
rotenone, antimycin A, cyanide) will also lead to an increase in mitochondrial 
NADH/NAD+, which clearly impacts PDH-mediated H2O2 generation (Figure 5).  Thus, 
experiments designed to identify the source of H2O2 in permeabilized fibers had to be 
performed in the absence of inhibitors and interpreted in the context of the ETS.  
Indirect evidence for PDH as the primary source of H2O2 during pyruvate-stimulated 
conditions was provided by comparing the impact of FCCP and ADP between pyruvate 
and succinate energized conditions.  Succinate-supported H2O2 is generated from site 
IQ of complex I due to reverse electron flow from complex II (i.e., succinate 
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dehydrogenase) (6), as well as a small contribution from the flavin moiety of succinate 
dehydrogenase itself (45), both of which are highly dependent on membrane potential.  
Indeed, confirming previous findings (3), succinate-supported H2O2 emission in 
permeabilized fibers was high under state 4 conditions, but completely eliminated when 
membrane potential was reduced by transition to state 3 (Figure 8B) or addition of the 
uncoupler FCCP (Figure 3C).  By contrast, pyruvate-stimulated JH2O2 emission 
remained significantly elevated under both maximal ADP- and FCCP-stimulated 
conditions, indicative of independence from mitochondrial membrane potential.  It is of 
interest to note that the absolute rate of pyruvate-supported JH2O2 emission was nearly 
identical under both respiratory conditions (~22 pmol/min/mg dry wt), despite the fact 
the experiments were conducted in permeabilized fibers from two different strains of 
mice with vastly different rates of pyruvate-stimulated H2O2 production rates under state 
4 conditions.  In permeabilized fibers with an intact redox buffering system (i.e, from 
C57BL/6N), pyruvate-supported JH2O2 emission increased from ~15 pmol/min/mg dry 
wt in state 4 to ~22 pmol/min/mg dry wt in response to FCCP (Figure 3A and 3C), most 
likely reflecting the balance between the increase in flux through the PDH complex and 
redox buffering capacity independent of membrane potential (i.e., +FCCP).  In 
permeabilized fibers inherently lacking membrane potential-dependent redox buffering 
(i.e., from C57BL/6J), pyruvate supported H2O2 emission was ~65 pmol/min/mg dry wt 
in state 4, then decreased to ~22 pmol/min/mg dry wt under maximal state 3 conditions 
(Figure 8A).  In this case, ADP titration gradually decreased pyruvate-supported JH2O2, 
most likely as a function of the oxidation of NADH/NAD+, eventually achieving the same 
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balance in flux through the PDH complex and net JH2O2 emission as in C57BL/6N fibers 
+FCCP.   
The remarkably divergent effects of carnitine on pyruvate-supported H2O2 production 
in fibers from C57BL/6N vs C57BL/6J mice reveal a dynamic interplay between the 
PDH complex and the redox buffering system.  Addition of carnitine to fibers with a 
functional NNT system increased pyruvate-supported JO2 and lowered H2O2 emission, 
consistent with relief of acetyl-CoA-mediated inhibition of PDH due to accelerated 
conversion of surplus acetyl-CoA to acetyl-carnitine and efflux out of the mitochondria 
(40).  However, addition of carnitine to fibers lacking functional NNT generated a similar 
increase in JO2 but a marked increase in pyruvate-supported H2O2 emission.  These 
findings suggest that flux through the PDH complex normally generates sufficient 
reducing power (i.e., NADH) to support NNT activity, keeping H2O2 emission by PDH in 
check.  In the absence of NNT however, reliance is limited to non-membrane potential 
dependent sources of NADPH (i.e., IDH and matrix malic enzyme), creating a limitation 
in the redox buffering system and thereby shifting the relationship between catalytic flux 
and net H2O2 emission by the PDH complex.  This emphasizes the importance of the 
redox buffering system to determining the overall impact of a given redox burden.  From 
an experimental design perspective, it is obvious divergent conclusions would have 
been drawn had either the C57BL/6N or C57BL/6J strains been used exclusively.  
These findings also raise the distinct possibility that the reduced redox buffering 
capacity of the C57BL/6J strain contributes to its increased susceptibility to diet-induced 
insulin resistance, emphasizing the point that genetic models developed on the 
C57BL/6J background must be interpreted in the context of the NNT deletion.             
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The dependence of PDH-derived H2O2 on matrix GSH content is a novel finding, as 
no other site was found to respond in a similar fashion, including αKGDH which is nearly 
identical structurally to PDH.  The level of decrease in GSH necessary to trigger an 
increase in H2O2 emission (~6-25% depletion) is observed in a variety of pathological 
conditions thought to have a reactive oxygen species-mediated component in their 
etiology, including diet-induced insulin resistance, diabetes, and aging (2, 50, 51).  The 
dependence of PDH-derived H2O2 on GSH appears to be specific to the glutathione 
molecule itself rather than direct interaction with a redox buffering enzyme-coupled 
system, as inhibition of both glutathione and thioredoxin reductases in the absence of 
GSH depletion only modestly increased pyruvate-supported H2O2 emission.  These 
findings imply the existence of some form of direct GSH-mediated scavenging and/or 
physical association with the PDH complex.  With respect to the latter, the E2-bound 
lipoyl moieties within the PDH complex are prime targets for glutathionylation, and 
indirect evidence for both reversible glutathionylation of the lipoyl groups bound to E2 in 
αKGDH (4), as well as direct interaction with thioredoxin and glutathione (8), have been 
reported.  However, using a direct immunoblotting approach (10, 31), we were unable to 
detect glutathionylation of the E2 component of PDH under several different 
experimental conditions (data not shown), supporting the former notion that GSH is 
functioning as a direct scavenger of H2O2 within the complex.  In this context, it is 
intriguing to consider the possibility that the high abundance of E2-bound lipoyl groups 
(3/E2 x 40 E2 = 120/PDH complex) may provide a source of reducing power to directly 
regenerate GSH from GSSG, creating an internal redox buffering circuit to 
counterbalance H2O2 production by the complex.  Such a mechanism could also protect 
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against irreversible inactivation of E1 by lipoate thiyl radicals that form when the 
complex is under elevated reducing pressure, a self-regulatory mechanism that has 
been observed in the αKGDH complex (8, 9).   
In aggregate, a potentially pivotal role of the PDH complex in mitochondrial and 
cellular redox circuitry has been indentified, highlighting the mechanisms distinguishing 
H2O2 production from H2O2 emission by the complex.  H2O2 production is determined by 
the reducing pressure exerted on the E2 lipoate residues, which in turn is dictated by 
the forward catalytic flux rate through the decarboxylation (E1) and transacetylation (E2) 
reactions relative to the NADH/NAD+ ratio.  Supply of pyruvate, as well as established 
allosteric (i.e., ↑ [acetyl-CoA]) and covalent (i.e., PDK-catalyzed phosphorylation) 
feedback mechanisms, regulate forward catalytic flux and thus the reducing ‘pressure 
head’, while availability of NAD+ determines the degree to which the pressure head is 
relieved.  Evidence suggests that GSH directly buffers H2O2 produced and is therefore 
crucial to determining the net rate of H2O2 emission by the PDH complex.  Under most 
circumstances, regeneration of GSH keeps pace with H2O2 production due to the 
glutathione and thioredoxin redox systems, both of which derive their reducing power 
from NNT-mediated NADPH in the presence of a functional ETS and source of NADH.  
The NADH needed for the NNT reaction, as well as the ETS, is at least in part supplied 
by the PDH reaction, thus creating a closed loop system allowing the PDH complex to 
buffer its own H2O2.  Interestingly, loss of this redox buffering system in and of itself 
does not appreciably increase pyruvate-supported H2O2 emission, but rather is likely to 
decrease the ability of the redox buffering cycle to maintain a GSH:GSSG ratio sufficient 
to fully buffer H2O2 and thus maintain protein cysteine redox status under a given rate of 
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reductive pressure.  To place in a physiological context, the implication is that conditions 
in which matrix GSH:GSSG ratio and/or total GSH content are reduced due to nutrient 
overload (e.g., high fat diet) (2), and/or the mitochondrial redox buffering system is 
compromised due to aging or disease (50, 51), will generate a net increase H2O2 
emission for a given degree of reductive pressure on the E2-bound lipoyl of the PDH 
complex.  
 
Experimental Procedures 
Animals and Reagents 
 All animal studies were approved by the East Carolina University Institutional Animal 
Care and Use Committee.  Male Sprague-Dawley rats (12-16 weeks old) and C57BL/6N 
mice were purchased from Charles River Laboratory.  C57BL/6J were purchased from 
Jackson Laboratory.  CrATM-/- were initially generated on a C57BL/6J background (40) 
and backcrossed to a C57BL/6N background for >8 generations (confirmed by genetic 
background testing, Charles River Laboratory). PDK4-/- mice were generated on a 
C57BL/6J background as described (27).  All rodents were housed in a temperature 
(22˚C) and light controlled (12 hour light/12 hour dark) room and maintained on 
standard chow with free access to food and water.  For all experiments, rodents were 
fasted 4 hours, anesthetized, and red portions of the gastrocnemius muscle dissected 
and separated into fiber bundles.  Remaining portions of muscle were frozen (liquid N2) 
for later analysis.  All reagents and chemicals were obtained from Sigma-Aldrich 
(including PDH from porcine heart and anti-protease cocktail) with the exception of 
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Amplex Ultra Red reagent (Invitrogen), GSH/GSSG assay kit (Oxis International Inc.), 
and recombinant PDK4 (Mitosciences).    
 
Preparation of permeabilized fiber bundles 
 This technique is partially adapted from previous methods and has been thoroughly 
described (44).  For experiments involving GSH depletion, 1-Chloro-2,4-dinitrobenzene 
(CDNB) or ethanol was added during saponin permeabilization.  Following 
permeabilization, fibers were washed in ice-cold buffer Z (K-MES [110 mM], KCl [35 
mM], EGTA [1 mM], K2HPO4 [5 mM], MgCl2-6H2O [3 mM], BSA [0.5 mg/ml] pH 7.1, 295 
mOsm) to remove endogenous substrates and un-reacted CDNB.  This method has 
previously been shown using isolated mitochondria to prevent direct CDNB-derived 
superoxide generation (58).  In addition, CDNB alone was shown to severely interfere 
with the Amplex Ultra Red/HRP detection system (data not shown), thus further 
emphasizing the need to wash out all unreacted CDNB prior to experimentation.  
Confirmation of CDNB washout was inferred based on a lack of increase in resorufin 
fluorescence during glutamate/malate energized conditions compared to that elicited in 
fibers which were not exposed to CDNB.     
 
Mitochondrial respiration and H2O2 emission measurements 
 High-resolution O2 consumption measurements were conducted at 37˚C in buffer Z, 
supplemented with creatine monohydrate (25mM), using the OROBOROS O2K 
Oxygraph.  Mitochondrial H2O2 emission was measured fluorometrically at 37˚C via 
Amplex Ultra Red (10 µM) / horseradish peroxidase (HRP: 3 U/ml) detection system 
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(Ex:Em 565:600).  Fluorescence was monitored using a SPEX Fluoromax 3 (HORIBA 
Jobin Yvon) spectrofluorometer with temperature control and magnetic stirring.  For 
each experiment, resorufin fluorescence was converted to nM H2O2 via an H2O2 
standard curve (Supplemental Figure 3A-B) generated under identical substrate 
conditions (with the exception of a permeabilized fiber) as employed for each protocol.  
To this end, all substrates utilized were tested for any potential interference with the 
Amplex Ultra Red/HRP detection system (Supplemental Figure 3C).  Blebbistatin (25 
µM) was present during all O2 consumption and H2O2 emission experiments to prevent 
contraction (44).  At the conclusion of each experiment, fiber bundles were washed in 
double-distilled H2O to remove salts and freeze-dried in a lyophilizer (Lab-conco).  The 
rate of respiration was expressed as pmol/s/mg dry weight and H2O2 emission as 
pmol/min/mg dry weight.   
 
Mitochondrial NADH production 
 All NADH production assays were carried in a potassium phosphate based buffer 
(50 mM), containing CaCl2 (10 µM) and MgCl2 (200 µM), pH 7.4.  Permeabilized fibers 
were prepared as indicated above.  Following a 15 minute wash in buffer Z, fibers were 
incubated with the pore-forming peptide alamethicin (30 µg/ml) in order to permeabilize 
the inner mitochondrial membrane (53).  Experiments were carried out in the presence 
of coenzyme A (100 µM), NAD+ (1 mM), thiamine pyrophosphate (300 µM), rotenone (2 
µM) and the indicated substrates.  NADH production was tracked via auto-fluorescence 
(Ex:Em 376/450).  Fluorescence values were converted to µM NADH via an NADH 
standard curve.   
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Isolated PDH experiments 
 All experiments were carried using PDH from porcine heart (Sigma-Aldrich) in 
potassium phosphate buffer as described above with the addition of coenzyme A (100 
µM) and thiamine pyrophosphate (300 µM).  The enzyme concentration for all assays 
was 16.8 mU/ml.  For H2O2 emission experiments, buffer was supplemented with 
Amplex Ultra Red (10 µM) and HRP (3 U/ml).  Coenzyme A was found to increase 
fluorescence, thus all H2O2 emission experiments were performed after an 8 minute 
recording of fluorescence in the absence of substrate.  Coenzyme A-induced 
fluorescence was subtracted out prior to data analysis.  NADH production was 
assessed as stated above.  Data are expressed as pmol/s/U.   
 
GSH measurements 
 Fiber bundles were homogenized in HEPES (3 mM), sucrose (25 mM), and EGTA 
(0. 5mM), pH 7.2.  Buffer was supplemented on the day of experimentation with 1% 
Triton and an anti-protease cocktail.  Total GSH was measured using the reagents and 
calibration set provided by the GSH/GSSG assay.   
 
Human subjects and tissue biopsy 
 Three healthy men and 2 women were recruited to participate in this investigation 
(age 26.2 ± 6.1, BMI 25.2 ± 3.7).  None of the subjects had any disease or were taking 
medications known to alter metabolism.  Subjects were given both oral and written 
information about the experimental procedures before giving their informed consent.  
 38 
 
The experiments were approved by the Institutional Review Board of East Carolina 
University and conducted in accordance with the Declaration of Helsinki principles.  On 
the day of the experiment, subjects reported to the laboratory following an overnight fast 
(12 hours).  Skeletal muscle biopsies were obtained from the lateral aspect of the 
vastus lateralis by the percutaneous needle biopsy technique under local subcutaneous 
anesthesia (1% lidocaine) and used to prepare permeabilized fiber bundles.   
 
Statistics 
 Data are presented as mean ± SEM.  Statistical analysis were performed using t-
tests or 1-way ANOVA with Student-Newman-Keuls methods for analysis of significance 
among groups.  The level of significance was set at P < 0.05. 
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Figure 3. Effects of FCCP and GSH depletion on site-specific mitochondrial H2O2 
emission.  Permeabilized fibers were prepared from RG of C57BL/6N mice (A-C, E-G), 
SD rats (H), or vastus lateralis from human biopsies (I) and pre-treated with varying 
concentrations of CDNB. H2O2 emission rate (JH2O2) was assessed in response to 
glutamate-malate (GM 10 mM-2 mM), palmitoyl-carnitine (PC 25 µM), α-ketoglutarate 
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(AKG 10 mM), glycerol-3-phosphate (G3P 10 mM), succinate (Succ 10 mM), pyruvate 
(Pyr 1 mM).  Maximal concentrations of FCCP-5 µM were added at the end of each 
protocol (A) *Different from GM, PC, AKG, G3P (p < 0.05).  **Different from all other 
substrate combinations (p < 0.05). (B) Representative H2O2 emission experiment in 
response to Succ and FCCP (left Y-axis) or Pyr and FCCP (right Y-axis). (C) Quantified 
rates (FCCP effect only) from experiment depicted in panel B, as well as the remaining 
substrate combinations. *Different from all other substrate combinations (p < 0.05).  (D) 
GSH was assessed in fibers pre-treated with varying concentrations of CDNB. Percent 
values inside bars represent mean percent reductions from the 0 µM condition. 
*Different from 0 µM condition (p < 0.05).  (E) Representative H2O2 emission experiment 
in response to Succ or Pyr in fibers pre-treated with 1 µM CDNB (dry weights of fibers 
for each experiment were within 0.01 mg). (F) Quantified rates (CDNB effect) from 
experiment depicted in panel E, as well as the remaining substrate combinations.  
Numbers above bars represent P values from paired t-tests comparing control (i.e., 
panel A) to CDNB-treated fibers within a substrate group. *Higher than all other 
substrate combinations (p < 0.05).  (G-I) Fibers were pre-treated with varying 
concentrations of CDNB and pyruvate (1 mM) supported H2O2 emission was then 
assessed.  GSH data are presented as % change from ethanol control.  GSH data from 
panel G was reproduced from panel D and expressed as % Change from control.  
*Different from 0 µM condition (p <0.05). Data are mean ± SEM, n=6/group. 
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Figure 4. H2O2 production from isolated PDH.  (A)  Cartoon schematic of the PDH 
reaction: 1. Pyruvate is decarboxlated by E1 to form hydroxyethyl thiamine 
pyrophosphate (HE-TPP). 2. Hydroxyethyl group is transferred to lipoate and oxidized to 
form acetyl dihydrolipoate. 3. Acetyl group is transferred to CoA to form acetyl-CoA. 4a. 
Dihydrolipoate is oxidized back to lipoate via the FAD moiety within E3, 4b. Reduced 
FAD is oxidized by NAD+ resulting in the formation of NADH.  (B-G) Data were 
generated using PDH from porcine heart.  (B) Representative H2O2 production 
experiment. Black arrows indicate the addition of pyruvate (1 mM).  (C) H2O2 production 
in response to increasing concentrations of NADH.  (D) Representative H2O2 production 
experiment in response to both 1 mM pyruvate and 100 µM NADH following incubation 
of isolated PDH with 2 mM NEM, 1 mM DPI, or both.  (E) Quantified rates of production 
from experiment depicted in panel D.  (F) H2O2 production was assessed in the absence 
and presence of 25 U/ml SOD.  (G) H2O2 production was assessed in the absence and 
presence of 100 U/ml catalase.  For these experiments, HRP was reduced to 100 
mU/ml in order to allow catalase to outcompete HRP for any potential H2O2.  All data 
are mean ± SEM, n=3-4/group. 
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Figure 5. Pyruvate-supported JH2O2 from isolated PDH is a function of E2 
reducing pressure.  H2O2 production was assessed in response to increasing 
concentrations of pyruvate in the absence (A) or presence (B) of NAD+.  Km and Vmax 
values (with respect to H2O2 production) were calculated using Prism statistical 
software.  *Different from - NAD+ condition.  (C) H2O2 production was assessed in 
response to increasing concentrations of NAD+ in the presence of 1 mM pyruvate.  
NAD+ concentrations were converted to logarithmic values and an IC50 value was 
obtained.  (D) Representative H2O2 production (red trace) and NADH production (blue 
trace) experiment in response to 1 mM pyruvate and 5 mM oxaloacetate (50 µM NAD+ 
was present for all assays).  (E) Pyruvate-supported H2O2 and NADH production were 
assessed in the presence of 50 µM NAD+.  JH2O2 and JNADH were plotted together 
(pmol/sec).  (F) Quantified JH2O2 from experiment depicted in panel D.  In addition to 
the peak, H2O2 production was quantified for the first 30 seconds following pyruvate 
addition, as well as following OAC administration.  *Different from all other conditions (p 
< 0.05).  (G) Isolated PDH was incubated with recombinant PDK4 protein for 10 minutes 
at room temperature in the absence or presence of 2 mM ATP.  H2O2 and NADH 
production were then assessed.  *Different from Con (p < 0.05).  (H-I) Pyruvate 
supported oxygen consumption (H) and H2O2 emission (I) was assessed in 
permeabilized fibers prepared from RG PDK4-/- mice and WT (C57BL/6J) controls.  
*Different from WT mice (p < 0.05). Data are mean ± SEM, (A-G) n = 3-4/group, (H-I) n 
= 7/group. 
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Figure 6. Differential effects of carnitine and malate on pyruvate-supported JO2, 
JNADH and JH2O2.  (A-I) Permeabilized fibers were prepared from mouse RG.  (A) JO2 
consumption in response to 1 mM pyruvate and 5 mM carnitine under state 4 
conditions.  *Different from Pyr (p < 0.05).  (B) Representative NADH production 
experiment in response to 1 mM pyruvate and 5 mM carnitine.  Fibers were pre-
incubated in alamethicin (30 µg/ml) prior to assay to permeabilize mitochondria.  
Numbers above trace represent mean NADH production rates (pmol/sec/mg).  (C) 
JH2O2 emission in response to 1 mM pyruvate and 5 mM carnitine under state 4 
conditions in fibers pre-treated with varying concentrations of CDNB.  *Different from 
Pyr (p < 0.05).  (D)  Representative H2O2 emission experiment following addition of 1 
mM pyruvate and 5 mM carnitine in the presence or absence of BCNU (100 µM) and AF 
(0.5 µM).  (E) Quantified JH2O2 emission rates from experiment in panel D.  *Different 
from – BCNU/AF (p < 0.05).  (F-G) Permeabilized fiber bundles were prepared from RG 
of CrATM-/- and their WT littermates (n = 5-6/group).  JH2O2 emission was assessed in 
response to 1mM pyruvate and 5 mM carnitine, either in the absence (F) or presence 
(G) of BCNU/AF.  *Different from WT (p < 0.05).  (H-I) JH2O2 emission in response to 1 
mM pyruvate and 2 mM malate in the absence (H) and presence (I) of BCNU/AF.  
*Different from Pyr condition (p < 0.05).  Data are mean ± SEM, n = 6-10/group. 
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Figure 7. Impact of NNT function/expression on PDH-supported JH2O2.  
Permeabilized fibers were prepared from RG of C57BL/6N (A-B) and C57BL/6J (B-D) 
mice.  (A) JH2O2 emission in response to sequential addition of 1 mM pyruvate, 5 µM 
FCCP and 5 mM carnitine.  *Different from Pyr condition (p < 0.05).  (B) Representative 
H2O2 emission experiment following the addition of 1 mM pyruvate and 5 mM carnitine 
in fibers prepared from C57BL/6N (black trace) and C57Bl/6J (red trace) mice.  (C) 
Quantified JH2O2 emission rates from experiment in panel B.  *Different from C57BL/6N 
(p < 0.05).  (D) JH2O2 emission in response to sequential addition of 1 mM pyruvate, 5 
mM carnitine, 2 mM malate, and BCNU/AF (100/0.5 µM).  *Different from Pyr (p < 0.05).  
Data are mean ± SEM, n = 7/group.  
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Figure 8.  PDH-supported H2O2 production under maximal ADP-stimulated 
conditions.  Permeabilized fibers were prepared from RG of C57BL/6J (A) and 
C57BL/6N (B) mice.  For all experiments, assay buffer was supplemented with 
hexokinase (1 U/ml) and 2-deoxyglucose (5 mM) to clamp ADP at each desired 
concentration.  (A)  Pyruvate (1 mM) and carnitine (5 mM)-supported H2O2 emission in 
response to increasing concentrations of ADP (0, 5, 50, 500, 2000 µM).  (B) JO2 
consumption and JH2O2 emission experiments were conducted in response to succinate 
(10 mM), pyruvate/carnitine (1 mM/5 mM), and glutamate/malate (10 mM/2 mM) in the 
absence (state 4) and presence (state 3) of maximal ADP (2 mM).  Both BCNU (100 
µM) and AF (0.5 µM) were present for all assays.  Data are presented as the ratio of 
H2O2 produced (pmol/sec/mg) to O2 consumed (pmol/sec/mg) under state 4 and state 3 
conditions.  *Different from all other groups under state 4 and state 3 conditions (p < 
0.05); **Different from G/M under state 4 conditions (p < 0.05).  Data are mean ± SEM, 
n = 6-7/group. 
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Supplemental Figure 1, Related to Figure 3. CDNB does not impact pyruvate-
supported oxygen consumption or NADH production.  Permeabilized fiber bundles 
were prepared from RG of C57BL/6N mice and pre-treated with varying concentrations 
of CDNB (n = 6/group).  (A) Oxygen consumption in response to pyruvate 1 mM and 
carnitine 5 mM under state 4 and state 3 conditions (ADP 2 mM).  *Different from 0 µM 
condition.  (B) Rate of NADH production in response to pyruvate 1 mM and carnitine 5 
mM.  Fibers were pre-incubated in alamethicin (30 µg/ml) prior to assay in order to 
permeabilize mitochondrial membrane.  Data are mean ± SEM. 
 
Supplemental Figure 2, Related to Figure 7. Effects of carnitine and malate on 
pyruvate-supported JO2 in wild-type and carnitine acetyltransferase (CrAT) 
knockout mice.  (A) Permeabilized fiber bundles were prepared from RG of muscle 
specific CrAT knockout mice (CrATm-/-) and their WT littermates (n = 5-6/group).  
Oxygen consumption was assessed in response to pyruvate 1 mM and carnitine 5 mM.  
*Different from WT (p < 0.05).  (B)  Permeabilized fiber bundles were prepared from RG 
of C57BL/6N mice (n = 4/group).  Oxygen consumption was assessed in response to 
pyruvate 1 mM and malate 2 mM under state 4 conditions.  *Different from Pyr condition 
(p < 0.05).  Data are mean ± SEM. 
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Supplemental Figure 3, Related to Experimental Procedures.  (A) Representative 
trace of an H2O2 standard curve experiment.  Black arrows indicate the addition of 
H2O2.  It is critical to understand that the background fluorescence using the Amplex 
Ultra Red/HRP detection system increases over time, as all experiments are run at 
37˚C.  To control for this, fluorescence is monitored for a period of ~8-10 minutes during 
each experiment prior to H2O2/substrate addition in order to quantify this background 
rate (extrapolated background fluorescence is depicted by the dotted line).  This 
background rate of fluorescence is then subtracted from each resorufin trace prior to 
slope and Y-intercept calculation (for standard curve experiments) or conversion to nM 
H2O2 (H2O2 emission experiments).  (B) Representative H2O2 standard curve.  (C) 
Quantified slopes (resorufin A.U./H2O2) from H2O2 standard curve experiments 
performed in the presence of various substrates.  *Different from vehicle control (p < 
0.05).  Data are mean ± SEM.  (D) Representative traces of resorufin fluorescence in 
the presence of increasing concentrations of NADH.  Black arrows indicate µM additions 
of NADH. 
 
 
  
CHAPTER 3: LOSS OF FUNCTIONAL NICOTINAMIDE NUCLEOTIDE 
TRANSHYDROGENASE IN C57BL/6J MICE COMPROMISES SKELETAL MUSCLE 
REDOX BUFFERING CAPACITY AND ALTERS WHOLE BODY ENERGY 
METABOLISM 
 
Abstract 
Nicotinamide nucleotide transhydrogenase (NNT) utilizes mitochondrial 
membrane potential to drive the thermodynamically unfavorable reduction of NADP+ 
from NADH.  NADPH, once produced, then provides reducing power for the principle 
redox buffering networks (glutathione and thioredoxin) operating within the matrix.  
C57BL/6J mice are deficient in NNT due to a naturally occurring in-frame five exon 
deletion within the gene encoding NNT.  These mice are characterized by an increased 
susceptibility to develop obesity, insulin resistance and type II diabetes when placed on 
a HFD.  The present study was undertaken to determine the potential consequences of 
NNT loss within these mice on skeletal muscle mitochondrial function.  Results 
contained herein demonstrate a clear role for NNT in contributing to skeletal muscle 
mitochondrial redox buffering integrity as well as whole body-energy metabolism.  
These findings help to explain the increased susceptibility to obesity and insulin 
resistance previously observed in the C57BL/6J strain and are the first to demonstrate a 
role for NNT in contributing to whole body energetic demand.   
 
Introduction 
C57BL/6J mice are one of the most routinely employed animal models of glucose 
metabolism within the field of diabetes research.  These mice display symptoms of 
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glucose intolerance as early as 6 weeks of age (30) and are highly susceptible to the 
development of obesity, insulin resistance and overt type II diabetes when placed on a 
high fat diet (HFD) (30, 55, 56).  In an elegant series of experiments conducted by Toye 
et al., (57) the phenotype of the C57BL/6J strain was mapped to a naturally occurring 
in-frame five exon deletion within the nicotinamide nucleotide transhydrogenase (NNT) 
gene, which removes exons 7-11 of the mature peptide, effectively creating an NNT 
whole body knockout (16, 23).  This mutation is believed to have occurred sometime 
between 1970 and 1984 and is apparently specific to the pure C57BL/6J strain 
produced only by the Jackson Laboratory (http://jaxmice.jax.org/strain/000664.html).  
Follow up experiments in which functional NNT was reintroduced via transgenic 
expression successfully rescued the impaired insulin secretion and glucose intolerant 
phenotype of the C57BL/6J mice (16).  A role for NNT in controlling pancreatic insulin 
secretion was subsequently demonstrated using siRNA directed at the protein within an 
insulin secreting cell line (15).  With regards to the mechanism of action, loss of NNT is 
believed to elevate mitochondrial peroxide exposure within the beta cell in response to 
glucose uptake, thereby lowering the ATP:ADP ratio (through an as yet unidentified  
mechanism), delaying closure of the KATP channel and ultimately impairing first-phase 
insulin secretion (15, 46).  While the impact of NNT loss on insulin secretion within the 
C57BL/6J strain has been thoroughly investigated, very little is currently known about 
the effects of this mutation on other tissues, specifically within insulin sensitive 
peripheral tissues (e.g., skeletal muscle). 
NNT, along with NADP-linked isocitrate dehydrogenase and decarboxylating malate 
dehydrogenase (malic enzyme; also present in the cytosol) are responsible for 
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maintaining mitochondrial reducing power in the form of NADPH/NADP+.  NNT is 
particularly interesting in that it has been shown to account for approximately 50% of 
matrix NADPH (46) and exists as a proton-translocating enzyme that utilizes the 
electrochemical proton motive force (∆p) generated by the respiratory complexes to 
drive the thermodynamically unfavorable reduction of NADP+ from NADH (21).  Much of 
the literature thus far investigating the pathophysiological consequences of altered cell 
redox (i.e., “oxidative stress”) has primarily focused on the deleterious impact of 
elevated peroxide production in terms of disease etiology.  However; based on the 
current working model of the organization/structural characteristics of redox signaling 
networks, protein redox status is primarily dictated not by H2O2 production, but rather by 
supply of reducing power (i.e., NADPH) (17).  That is, alterations in cellular redox could 
just as easily be propagated via a reduction in NADPH supply as they could by an 
increase in H2O2 production.  This concept represents a potential paradigm shift within 
the field in which investigative emphasis is directed not only towards uncovering the 
specific proteins responsible for H2O2 generation, but also to those tasked with the 
maintenance of cellular reducing power (i.e., NADPH producing enzymes).  To this end, 
NNT represents an intriguing target of investigation given its overall contribution to 
matrix NADPH and dependence on mitochondrial energization.  The present study was 
undertaken to determine the potential consequences of NNT loss on skeletal muscle 
mitochondrial redox status and respiratory function, as well as whole body energy 
metabolism.  Results contained herein demonstrate a clear role for NNT in controlling 
mitochondrial peroxide emission, particularly that arising from the pyruvate 
dehydrogenase complex (PDH).  In addition, a role for NNT in contributing to energetic 
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demand is demonstrated both at the mitochondrial level using a TPP+ selective 
electrode to assess mitochondrial membrane potential, as well as at the whole body 
level via indirect calorimetry.  With respect to the latter, C57BL/6J mice were found to 
consume less oxygen and thus have lower energy expenditure per gram of lean mass 
compared to C57BL/6N mice which express functional NNT.  These findings are the first 
to demonstrate a role for NNT in regulating both skeletal muscle redox homeostasis and 
whole body energy metabolism, both of which may contribute to the well characterized 
glucose intolerant and obesity prone phenotype of the C57BL/6J strain.      
 
Results 
Assessment of glucose tolerance and insulin sensitivity within C57BL/6N (6N) 
and C57BL/6J (6J) mice. 
 Consistent with previous reports demonstrating impaired glucose tolerance in 
C57BL/6J mice (30, 57), area under the curve (AUC) for blood glucose during an IPGTT 
was greater in the 6J mice at ~ 10 weeks of age (Figure 9A & 9B).  Fasting blood 
glucose however was not different (6N 160.6 ± 14.6; 6J 165.6 ± 11.3 mg/dl).  Both AUC 
for blood glucose during an ITT (Figure 9C) and ex vivo insulin-stimulated glucose 
uptake (Figure 9D) were not different, thus suggesting similar levels of insulin sensitivity 
between strains.     
Assessment of whole-body energy metabolism reveals stark differences in 
energy expenditure between strains 
 Assessment of terminal body composition revealed ~ 2 fold greater fat mass in 6J 
compared to 6N mice, despite no differences in lean or total body mass (Figure 9E).  
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These findings are in agreement with previous reports (41, 54) and provide evidence of 
differences in whole-body energy metabolism between strains.  To directly address this 
question, a separate cohort of 6N and 6J mice were placed inside indirect calorimetry 
units in which rates of oxygen consumption and carbon dioxide production were 
continuously monitored along with ambulatory activity and food/water intake for a period 
of 5 days.  Analysis revealed clear reductions in oxygen consumption (Figure 10A & 
10D), carbon dioxide production (Figure 10B & 10E) as well as calculated energy 
expenditure (Figure 10C & 10F) in the 6J mice.  These differences were apparent 
whether the data were normalized to fat free mass (Figure 10A-C) or total body mass 
(Figure 10D-F) and could not be explained by differences in RER (Figure 10G), food 
intake (Figure 10H) or ambulatory activity (Figure 10I).  The fact that normalization to fat 
free mass did not eliminate the apparent differences in energy metabolism suggested 
that the reduced oxygen consumption and energy expenditure observed in the 6J mice 
may be related to inherent differences in skeletal muscle metabolism, as skeletal 
muscle accounts for approximately ~ 40% of total body mass and ~ 30% of resting 
energy expenditure (62).        
No evidence of reduced mitochondrial content in C57BL/6J mice 
 To determine if strain differences in whole-body oxygen consumption may be related 
to mitochondrial content and/or functional capacity, protein abundance and respiratory 
capacity were assessed in skeletal muscle.  Assessment of protein content via 
immunoblot revealed no differences between strains for any of the respiratory 
complexes (Figure 11A).  As an index of functional capacity, maximal uncoupled 
respiration was assessed in permeabilized fibers prepared from red gastrocnemius 
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muscle under saturating substrate (10 mM glutamate, 2 mM malate, 2 mM ADP, 10 mM 
succinate, and 500 nM FCCP) conditions.  These experiments revealed no differences 
in respiratory capacity between strains (Figure 11B).  Collectively, these data do not 
support a role for reduced mitochondrial content and/or functional capacity in 
contributing to the altered energy metabolism observed in the 6J mice.   
 Loss of functional NNT compromises pyruvate-supported JO2 consumption and 
elevates mitochondrial membrane potential (∆Ψ)    
 While knockout of NNT in Caenorhabditis elegans (5), as well as PC12 cells (60) 
has indeed been shown to impair cellular redox homeostasis (oxidative shift in the 
glutathione pool), as well as increase sensitivity to peroxide exposure, and alter energy 
metabolism (reduced respiration and levels of ATP), very little is currently known as to 
how loss of this protein may affect skeletal muscle mitochondrial function.  Given that 
NNT accounts for ~50% of matrix NADPH, coupled with the dependence of NNT 
function on mitochondrial membrane potential, it was hypothesized that loss of this 
protein may have far reaching consequences on mitochondrial function under substrate 
combinations designed to maximize NNT activity.  To test this hypothesis, JO2 
consumption and mitochondrial membrane potential (∆Ψ) were assessed in 
permeabilized fibers in the presence of pyruvate and carnitine or succinate alone.  The 
combination of pyruvate and carnitine provides a unique situation in which the pyruvate 
dehydrogenase complex (PDH) and NNT exist as the sole sources of NADH and 
NADPH, respectively.  Under these conditions, respiration rate was lower in fibers 
prepared from 6J mice both in the absence (state 4) and presence (state 3) of ADP 
(Figure 12A).  Mitochondrial membrane potential (∆Ψ) was not different under state 4 
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conditions (despite lower JO2 consumption in the 6Js), but was slightly more negative in 
the 6J mice upon transition to state 3 respiration (Figure 12B & 12D).  While the slightly 
more negative ∆Ψ in the 6J mice (6N -137.0 mV; 6J -143.7 mV) suggests a role for 
NNT in contributing to metabolic demand (i.e., ∆p consumption), these data do not rule 
out the possibility of potential oxidative modification made to PDH or the respiratory 
system as a consequence of reduced NADPH-dependent peroxide buffering.  To test 
this possibility, pyruvate/carnitine JO2 consumption experiments were repeated in the 
absence and presence of the thiol reducing agent dithiothreitol (DTT).  The addition of 
DTT completely normalized respiration rates between strains (Figure 12C), thus 
suggesting a role for H2O2-mediated oxidative modifications in contributing to the 
respiration impairments observed in the 6J mice. 
 Similar to pyruvate/carnitine, the provision of succinate as the sole substrate restricts 
NADPH supply to the level of NNT, with the exception of a small contribution from malic 
enzyme following succinate oxidation (succinate → fumarate → malate).  Under these 
conditions, reverse electron flow from complex II back to complex I results in the 
reduction of NAD+ to NADH, which can subsequently be utilized by NNT to provide 
NADPH at the expense of ∆Ψ.  In contrast to that observed for pyruvate/carnitine, 
succinate supported respiration was not found to differ between strains under state 4 
conditions (Figure 12E).  However, assessment of succinate-supported ∆Ψ revealed a 
significantly more negative membrane potential in fibers prepared from 6J mice (6N -
194.5 mV; 6J -204.8 mV) (Figure 12F).  Taken together, these data support a role for 
NNT in contributing to metabolic demand under substrate conditions which rely on NNT 
as the principle source of NADPH.  Moreover, elevations in ∆Ψ coupled with apparent 
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reductions in peroxide-buffering capacity (evidenced by the DTT experiment) within the 
6J mice suggest the presence of severely elevated H2O2 emitting potential.              
Pyruvate and succinate-supported H2O2 emission are elevated in C57BL/6J mice. 
 As anticipated, assessment of JH2O2 emitting potential in permeabilized fibers 
prepared from 6N and 6J mice revealed ~ 2 fold greater emission rates in the 6J mice in 
response to pyruvate (Figure 13A).  In order to determine the impact of NNT on 
pyruvate alone-supported JH2O2 emission, NNT activity was inhibited using the 
chemical uncoupler FCCP.  Addition of FCCP following pyruvate increased JH2O2 
emission in the 6N mice to the level of the 6Js (Figure 13B), suggesting a role for NNT 
in regulating peroxide emission from NADH-linked dehydrogenases such as PDH.  
Assessment of JH2O2 emission in the presence of pyruvate and carnitine revealed 
drastic differences between strains (Figure 13C).  Compared to pyruvate-alone 
supported JH2O2 emission, the inclusion of carnitine increased JH2O2 emission in the 6J 
mice approximately 5 fold, while decreasing emission within the 6Ns (compare Pyr rates 
from Figure 13B to Pyr/Carn rates in Figure 13D).  As an aside, the divergent response 
to carnitine between the two strains is observed without exception, and as such can be 
used as a surrogate means of genotyping unknown strains of mice as either 6N or 6J.  
To determine the influence of NNT on pyruvate/carnitine supported JH2O2 emission, 
NADPH-dependent reductase activity (both glutathione and thioredoxin) was inhibited 
via bis-chloroethylnitrosourea (BCNU) and auranofin (AF).  In the presence of 
BCNU/AF, pyruvate/carnitine supported JH2O2 emission was unchanged in 6J mice and 
starkly elevated within the 6N mice, albeit not to the level of the 6Js (Figure 13C & 13D).  
Investigation into the individual contribution of glutathione reductase (GR) and 
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thioredoxin reductase (TrxR) to the control of pyruvate/carnitine supported JH2O2 
emission, revealed a greater contribution from TrxR (Figure 13E & 13F).  Pyruvate 
supported JH2O2 emission in the presence of malate was also elevated in the 6J mice; 
however, the addition of BCNU/AF completely normalized emission rates between 
groups (Figure 13G & 13H).  The lower emission rates in the presence of malate 
(compare Pyr rates from Figure 13B to Pyr/Mal rates in Figure 13H) are reflective of the 
ability of malate to supply reducing power (i.e., NADPH) independent of NNT activity via 
isocitrate dehydrogenase and malic enzyme.    
 Consistent with that observed in the presence of pyruvate, succinate supported 
JH2O2 emission was elevated ~ 2 fold in the 6J mice (Figure 14A).  The addition of 
BCNU and AF under succinate-energized conditions increased JH2O2 emission in both 
6N and 6J mice, with the effect being much more pronounced in the former (Figure 14B 
& 14C).  Emission rates in the presence of BCNU/AF were not found to be statistically 
different between strains.  Despite the stark differences in H2O2 emitting potential 
between strains, assessment of glutathione redox status within skeletal muscle 
homogenate from both soleus and tibialis anterior muscle revealed no differences 
(Figure 15A & 15B).  The lack of apparent oxidation within the glutathione pool may 
reflect the experimentally determined less dominant role of glutathione reductase in 
controlling peroxide emission compared to TrxR (Figure 13E &13F).  Alterations in 
thioredoxin redox status may have revealed strain differences; however, assessment of 
Trx redox state within tissue homogenate has several limitations and thus was not 
performed in the present study.  
Discussion 
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 The NNT-deficient C57BL/6J strain is a particularly useful model for the study of 
metabolic disease in that they possess a unique susceptibility to develop obesity, insulin 
resistance and type II diabetes when fed a HFD (30, 54, 55).  While impairments in first-
phase insulin secretion have been identified as the principle factor responsible for the 
glucose intolerant phenotype of the C57BL/6J line (15), these defects do not explain the 
propensity for body fat accumulation and/or peripheral insulin resistance also observed 
in these mice.  Given the growing body of literature suggestive of a “causal” role for 
altered cellular redox status in the development of insulin resistance (2, 22) in 
conjunction with the importance of NNT in maintaining redox homeostasis (5, 60), it was 
hypothesized that loss of NNT within C57BL/6J mice may have additional impacts 
particularly within skeletal muscle mitochondria which may contribute to their increased 
propensity for metabolic disease.  In this context, there are three main findings from the 
present study.  First, NNT was shown to be a critical component of the mitochondrial 
redox buffering network operating within skeletal muscle.  Loss of this function in 
C57BL/6J mice was shown to severely elevate mitochondrial H2O2 emitting potential as 
well as disrupt pyruvate supported respiratory kinetics.  Second, NNT deficiency was 
found to generate a more negative ∆Ψ in the presence of pyruvate/carnitine/ADP and 
succinate.  To our knowledge, this is the first evidence portraying a role for NNT in the 
dissipation of ∆p under physiological constraints.  Lastly, lack of NNT in C57BL/6J mice 
was shown to result in reduced whole body oxygen consumption and energy 
expenditure compared to C57BL/6N mice, despite similar levels of activity and food 
intake.  Collectively, the present findings expand the function of NNT beyond the level of 
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an NADPH-generating enzyme and establish the protein as a critical regulator of both 
matrix redox buffering capacity and energetic demand.    
The mitochondrial respiratory system is comprised of several multi-polypeptide protein 
complexes embedded within the inner mitochondrial membrane.  Electrons derived from 
the oxidation of carbon-based substrates are transferred through a series of redox 
couples within these complexes with O2 serving as the final electron acceptor, ultimately 
reducing ½O2 to H2O (13).  Energy released during electron transfer is harnessed at 
three locations within the respiratory system to drive the translocation of protons from 
the matrix to the inner membrane space.  This creates a proton gradient across the 
inner membrane that is derived from both the concentration and the electrical potential 
difference across the membrane, collectively referred to as the proton motive force (∆p).  
The electrical-chemical potential energy created by the generation of ∆p is sufficient to 
drive the synthesis of ATP as protons flow back through the ATP synthase complex into 
the matrix.  While ATP synthase is the principle consumer of ∆p, a variety of other 
energy-dependent cellular processes are dependent upon ∆p within the matrix.  These 
include, adenine nucleotide translocase (ANT), calcium uptake, substrate transport and 
NNT activity.  These energy-consuming processes combine to determine the energetic 
demand within the system at any point in time.  A key point to emphasize is that both 
the generation and dissipation of ∆p is a “demand” driven process. That is, the oxidation 
of substrate and subsequent flux of electrons throughout the respiratory system is 
determined by the rate of ∆p consumption.  From a whole organism perspective, a 
greater rate of oxygen consumption corresponds to a greater rate of ∆p consumption 
(i.e., high demand), whereas reduced oxygen consumption reflects a slower rate of ∆p 
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consumption (i.e., low demand).  In the present study, C57BL/6J mice, which lack 
functional NNT and thus lack any potential contribution by the enzyme to ∆p dissipation, 
were found to have lower whole body oxygen consumption per gram of fat free mass.  
These data provide rather compelling evidence for a role of NNT in contributing to whole 
body energy expenditure and thus may explain the previously reported increased 
susceptibility to diet-induced obesity in C57BL/6J mice (41, 54), as well as the 
increased adiposity observed herein. 
In addition to whole-body adiposity, mitochondrial electron leak and subsequent 
formation of O2•/H2O2 is also highly sensitive to metabolic demand.  Periods of 
increased nutrient delivery (i.e., ↑NADH/NAD+) in the face of low energetic demand (i.e., 
↓ ∆p consumption) elevate reducing pressure within the respiratory system as well 
certain H2O2 generating dehydrogenases (e.g., PDH, KGDH), and have been shown to 
promote maximal rates of electron leak (34, 37, 38, 53).  This increase in propensity for 
electron leak in response to nutrient overload has been suggested to play a causal role 
in the development of high fat diet-induced insulin resistance (2, 20, 22).  In response to 
high fat feeding, an increased burden is immediately placed upon the redox buffering 
systems operating within the matrix to both attenuate excessive peroxide emission and 
prevent aberrant oxidation within the redox-sensitive proteome.  Evidence in support of 
this notion is supplied by several investigations in which supplementation of the redox 
buffering network via mitochondrial targeted transgenic and/or pharmacological 
interventions has been shown to protect against the onset of diet-induced insulin 
resistance (2, 11, 20).  Based on this concept, it is hypothesized that the clear 
reductions in redox buffering capacity observed in the present study within the 
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C57BL/6J mice may contribute to their increased susceptibility to develop insulin 
resistance when fed a HFD.  More to the point, loss of NNT would be expected to be 
particularly detrimental given its role in contributing not only to NADPH generation but 
also to ∆p dissipation; a function which serves to attenuate reducing pressure and 
electron leak throughout the system.  
In aggregate, the present study sheds valuable insight into a role for NNT in contributing 
to skeletal muscle mitochondrial redox buffering integrity as well as whole body-energy 
metabolism.  These findings help to explain the increased susceptibility to obesity and 
insulin resistance previously observed in the C57BL/6J strain and are the first to 
demonstrate a role for NNT in contributing to whole body energetic demand.  Future 
investigation is required in order to determine if indeed alterations in NNT 
activity/expression are involved in the etiology of metabolic disease.          
   
Experimental Procedures 
Animals and Reagents 
 All animal studies were approved by the East Carolina University Institutional Animal 
Care and Use Committee. C57BL/6NJ (6N) and C57BL/6J (6J) mice were purchased 
from Jackson Laboratory.  All mice were housed in a temperature (22˚C) and light 
controlled (12 hour light/12 hour dark) room and maintained on 10% low fat diet with 
free access to food and water.  For all experiments, mice were fasted 4 hours, 
anesthetized, and red portions of the gastrocnemius muscle were dissected and 
separated into fiber bundles.  Remaining portions of muscle were frozen (liquid N2) for 
later analysis.  All reagents and chemicals were obtained from Sigma-Aldrich with the 
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exception of Amplex Ultra Red reagent (Invitrogen), GSH/GSSG assay kit (Oxis 
International Inc.), and Total OXPHOS Rodent WB Antibody Cocktail (Mitosciences).    
 
Glucose and Insulin tolerance testing 
All experiments were performed following a 4 hour fast at approximately 12:00pm.  
Blood glucose was monitored using the Blood Glucose Alpha Track Monitoring System 
from samples collected at the distal tail vein.  Following an initial blood glucose 
measurement, glucose (2g/kg FFM) or insulin (0.5U/kg FFM) was injected 
intraperitoneally and glucose measurements were made every 10-20 minutes for a 
period of 90-120 minutes.    
 
3+H-2-Deoxyglucose uptake  
Immediately after removal, extensor digitorum longus muscles were placed 
inside pre-filled wells containing Krebs-Henseleit buffer (KHB) plus 1mM pyruvate with 
continuous bubbling of 95% O2-5% CO2 inside a temperature (37˚C) controlled water 
bath.  Following a 20 min pre-incubation period, muscles were transferred to fresh wells 
which did or did not contain insulin (50 mU/ml) for 30 min.  Muscles were then 
transferred to incubation wells containing 5mM 2-deoxyglucose (2-DOG), 10mM 
Mannitol, 0.2µCi/ml 3+H-2DOG, 0.01µCi/ml 14C-D-Mannitol, and with or without insulin 
(50 mU/ml).  After incubation, muscles were transferred to ice-cold KHB to stop 
reaction, trimmed of connective tissue and flash frozen until time of analysis.  Frozen 
muscles were weighed and solubilized in 0.1 ml of 0.5N NaOH.  Solubilized muscles 
and incubation media samples were counted in a Beckman LS 5000 TD liquid 
 63 
 
scintillation counter preset to count 14C and 3H channels simultaneously.  Data are 
expressed as µmol/g/hr.   
 
Determination of body composition   
Measurements of fat and lean body mass were determined using the EchoMRI-
500 (Houston, TX) in accordance with the manufacturer’s instructions. 
 
Assessment of whole-body energy metabolism  
The TSE LabMaster System (TSE Systems, Chesterfield, MO) was used to 
determine rates of oxygen consumption (VO2) and carbon dioxide production (VCO2), 
respiratory exchange ratio, food and water intake, and energy expenditure.  Rates are 
expressed per g of fat free mass (FFM) or body weight (BW).  Infrared sensors were 
used to record ambulatory activity in three-dimensional axes (X, Y, Z).  Counts across 
all three axes were summed to give total ambulatory activity.  All reported 
measurements represent the average of at least two 12 hour light or dark cycles.   
 
Preparation of permeabilized fiber bundles 
 This technique is partially adapted from previous methods and has been thoroughly 
described (44).  Following permeabilization, fibers were washed in ice-cold buffer Z (K-
MES [110 mM], KCl [35 mM], EGTA [1 mM], K2HPO4 [5 mM], MgCl2-6H2O [3 mM], BSA 
[0.5 mg/ml] pH 7.1, 295 mOsm) to remove endogenous substrates.       
 
Mitochondrial respiration and H2O2 emission measurements 
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 High-resolution O2 consumption measurements were conducted at 37˚C in buffer Z, 
supplemented with creatine monohydrate (25mM), using the OROBOROS O2K 
Oxygraph.  Mitochondrial H2O2 emission was measured fluorometrically at 37˚C via 
Amplex Ultra Red (10 µM) / horseradish peroxidase (3 U/ml) detection system (Ex:Em 
565:600).  Fluorescence was monitored using a SPEX Fluoromax 3 (HORIBA Jobin 
Yvon) spectrofluorometer with temperature control and magnetic stirring.  For each 
experiment, resorufin fluorescence was converted to nM H2O2 via an H2O2 standard 
curve generated under identical substrate conditions (with the exception of a 
permeabilized fiber) as employed for each protocol.  To this end, all substrates utilized 
were tested for any potential interference with the Amplex Ultra Red/HRP detection 
system.  Blebbistatin (25 µM) was present during all O2 consumption and H2O2 emission 
experiments to prevent contraction (44).  At the conclusion of each experiment, fiber 
bundles were washed in double-distilled H2O to remove salts and freeze-dried in a 
lyophilizer (Lab-conco).  The rate of respiration was expressed as pmol/s/mg dry weight 
and H2O2 emission as pmol/min/mg dry weight.   
 
Mitochondrial Membrane Potential (∆Ψ)   
∆Ψ and respiration rates of PmFBs were measured simultaneously using the 
OROBOROS Oxygraph-2k (Oroboros Instruments) combined with electrodes sensitive 
to TPP+ (tetraphenylphosponium, a membrane-potential dependent probe) and oxygen 
at 25°C.  All experiments were run in Buffer Z containing 20 mM creatine monohydrate 
and 25 µM blebbistatin.  Individual protocols included: (1) (in mM) 2 malate, 10 
glutamate, 15 pyruvate, 10 succinate, 10 glycerol-3-phosphate, 5 2-deoxyglucose, 2 
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U/mL hexokinase + ADP titration (25, 50, 100, 250, 500, 1000, 2000 µM) + 2 µM FCCP; 
(2) (in mM) 2 malate, 10 glutamate, 15 pyruvate + 10 succinate + 2 ADP + 2 µM FCCP.  
For each protocol the TPP+ electrode was calibrated by a 5 point titration (1.1-1.5 µM 
TPP+) for quantifying the concentration of TPP+. 
The calculation of ∆Ψ is based on the Nernst equation with binding correction 
factors and estimated mitochondrial protein content to PmFB freeze-dried weight.  The 
Oroboros TPP+- ∆Ψ calculation template (www.oroboros.at) was used with the following 
equation:  
 
 
 
Variables and constants of the equation include: nadd = total amount of ions added to 
system; cext,free = free concentration of probe ion outside mitochondria; Vext = volume of 
external solution outside mitochondria; Vmt = volume of mitochondrial matrix (1 µl/mg 
(35)); Ki’ = internal partition coefficient of TPP+ (7.9 µl/mg (35)); Ko’ = external partition 
coefficient of TPP+ (14.3 µl/mg (35)); Pmt = total mitochondria protein content (7.5% of 
mg dry weight) (24, 42); Pc = total cellular protein content (equivalent to PmFB mg dry 
weight). 
 
Western blot analysis   
Frozen muscles were homogenized in TE buffer (10 mM Tris, 1 mM EDTA), 
supplemented with an anti-protease cocktail (Sigma) and combined 1:1 with Laemmli 
Sample Buffer (Bio-Rad), which contained 10 mM dithiothreitol (DTT).  Proteins were 
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separated by SDS-PAGE and electrotransferred to polyvinylidene fluoride (PVDF) 
membranes (Millipore, Billerica, MA).  Membranes were blocked for 1 hour at room 
temperature using Odyssey Blocking Buffer (LI-COR Biosciences) and then probed 
overnight (4˚C) with a Total OXPHOS Rodent WB Antibody Cocktail (1:1000) 
(Mitosciences).  Following washing, membranes were incubated for 1h at room 
temperature with a mouse secondary antibody and the immunoreactive proteins were 
detected using the Odyssey infrared imagining system.  Results were normalized for 
total protein using MemCode Reversible Protein Stain (Pierce, Rockford, IL). 
 
GSH, GSSG, GSH/GSSG measurements 
 Frozen muscles were homogenized in TE buffer (10 mM Tris, 1 mM EDTA) that was 
pre-bubbled with N2 gas for ~20 minutes prior to homogenization.  Bubbling of N2 gas 
prior to homogenization was found to be critical in preventing ex-vivo oxidation of the 
glutathione pool.  Immediately following homogenization, a portion of homogenate was 
transferred to a separate tube containing 0.5 mM 1-methyl-2-vinylpyridinium triflate 
(M2VP), which was utilized to assess GSSG.  Samples were spun down (10,000 RPM, 
4˚C) and supernatant was utilized to measure GSH and GSSG using the reagents and 
calibration set provided by the GSH/GSSG assay kit (Percipio Biosciences).   
 
Statistics 
 Data are presented as mean ± SEM.  Statistical analysis were performed using t-
tests or 1-way ANOVA with Student-Newman-Keuls methods for analysis of significance 
among groups.  The level of significance was set at P < 0.05. 
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Figure 9.  Differences in glucose tolerance and terminal body composition 
between C57BL/6N and C57BL/6J mice.  (A) Intraperitoneal glucose (2g/kg FFM) 
tolerance tests were performed at ~10-12 weeks of age.  (B) Area under the curve 
(AUC) was calculated using Prism statistical software.  (C) Intraperitoneal insulin 
(0.5U/kg FFM) tolerance tests were performed at ~10-12 weeks of age.  (D) Basal and 
insulin (50mU/ml) stimulated 3H-2-deoxyglucose uptake was assessed in EDL muscle at 
~12-14 weeks of age.  (E) Fat and lean body mass were determined using the 
EchoMRI-500 (Houston, TX) at ~10-12 weeks of age.  *Different from Pyr condition (p < 
0.05).  Data are mean ± SEM, n = 9-10/group. 
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Figure 10.  Reduced whole body O2 consumption and energy expenditure in 
C57BL/6J mice, despite similar levels of activity and food intake.  Indirect 
metabolic calorimetry and ambulatory activity in C57BL/6N and C57BL/6J mice.  (A) 
Oxygen consumption and (B) Carbon dioxide production (C) calculated energy 
expenditure per gram of fat free mass.  (D) Oxygen consumption (E) Carbon dioxide 
production and (F) calculated energy expenditure per gram of total body weight.  (G)  
Calculated respiratory exchange ratio. (H) Food intake per 24 hour period.  (I) 
Ambulatory activity.  *Different from 6N mice within either the Light or Dark Cycle (p < 
0.05).  Data are mean ± SEM, n=13/group. 
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Figure 11.  Markers of mitochondrial content are similar between C47BL/6N and 
C57BL/6J mice.  (A) Western blot of mitochondrial complexes performed using 
homogenate prepared from frozen TA muscle. (B)  Maximal uncoupled respiration was 
assessed in permeabilized fibers prepared from RG of C57BL/6N and C57BL/6J mice.  
Substrates included 10 mM glutamate, 2 mM malate, 2 mM ADP, 10 mM succinate, and 
500 nM FCCP.    Data are mean ± SEM, n=6-10/group.       
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Figure 12.  Differences in JO2 consumption and mitochondrial membrane 
potential (∆Ψ) between C57BL/6N and C57BL/6J mice.  (A-F) Permeabilized fibers 
were prepared from RG of C57BL/6N and C57BL/6J mice.  (A) Oxygen consumption 
was assessed in response to 1 mM pyruvate, 5 mM carnitine and 2 mM ADP.  *Different 
from C57BL/6N mice (p < 0.05).  (B) Quantified  ∆Ψ in the presence of 
pyruvate/carnitine (1 mM/5 mM) under state 4 and state 3 (2 mM ADP) conditions.  (C) 
Oxygen consumption was assessed in response to 1 mM pyruvate, 5 mM carnitine and 
2 mM ADP in the absence (- DTT) or presence of 0.5 mM DTT (+ DTT).  *Different from 
all other conditions (p < 0.05).  (D) Representative experiment depicting the assessment 
of ∆Ψ in the presence of pyruvate/carnitine (1 mM/5 mM).  Trace reflects the voltage 
signal obtained in response a 5 point TPP+ titration (1.1-1.5µM), following the addition of 
a permeabilized fiber and 2 mM ADP.  (E) Oxygen consumption was assessed in 
response to 10 mM succinate.  (F)  Quantified ∆Ψ in the presence of succinate (10 mM) 
under state 4 conditions.  *Different from C57BL/6N mice (p < 0.05).  Data are mean ± 
SEM, n=10-15/group.    
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Figure 13.  Pyruvate-supported JH2O2 emission is elevated in C57BL/6J mice.  (A-
H) Permeabilized fibers were prepared from RG of C57BL/6N and C57BL/6J mice.  (A) 
JH2O2 emission in response to pyruvate (1 mM) alone.  *Different from C57BL/6N (p < 
0.05).  (B) JH2O2 emission following the sequential addition of 1 mM pyruvate (Pyr) and 
500 nM FCCP (PyrFCCP).  *Different from C57BL/6N (p < 0.05).  (C) Representative 
JH2O2 emission experiment following the sequential addition of 1 mM/5 mM 
pyruvate/carnitine (Pyr/Carn) and 100 µM/1 µM BCNU/auranofin (BCNU/AF).  (D) 
Analyzed rates of JH2O2 emission from experiment depicted in panel C.  *Different from 
C57BL/6N (p < 0.05); ϕ Different from Pyr/Carn rate in C57BL/6N mice (p < 0.05).  (E) 
Representative JH2O2 emission experiment performed in C57BL/6N mice only following 
the sequential addition of 1 mM/5 mM pyruvate/carnitine (Pyr/Carn), 100 µM BCNU and 
1 µM AF.  (F) Analyzed rates of JH2O2 emission from experiment depicted in panel E.  
*Different from Pyr/Carn (p < 0.05); **Different from +BCNU (p < 0.05).  (G) 
Representative JH2O2 emission experiment following the sequential addition of 1 mM/2 
mM pyruvate/malate (Pyr/Mal) and 100 µM/1 µM BCNU/auranofin (BCNU/AF).  (H) 
Analyzed rates of JH2O2 emission from experiment depicted in panel G.  *Different from 
C57BL/6N (p < 0.05).  Data are mean ± SEM, n=10-15/group.                    
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Figure 14.  Succinate-supported JH2O2 emission is elevated in C57BL/6J mice.  
(A-C) Permeabilized fibers were prepared from RG of C57BL/6N and C57BL/6J mice.  
(A) JH2O2 emission in response to succinate (10 mM) alone.  *Different from C57BL/6N 
(p < 0.05).  (B) Representative JH2O2 emission experiment following the sequential 
addition of 10 mM succinate and 100 µM/1 µM BCNU/auranofin (BCNU/AF). (C) 
Analyzed rates of JH2O2 emission from experiment depicted in panel B.  *Different from 
C57BL/6N (p < 0.05); ϕ Different from corresponding – BCNU/AF rate (p < 0.05).  Data 
are mean ± SEM, n=10-15/group.     
 
 
Figure 15.  Glutathione redox status is unaltered in C57BL/6J mice.  (A-B) 
Reduced (GSH) and oxidized (GSSG) glutathione, as well as the ratio of GSH/GSSG 
were assessed in homogenate prepared from frozen soleus (A) and TA (B) muscle.   
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CHAPTER 4: INTEGRATED DISCUSSION 
Major Findings 
The production of H2O2 within biological systems was originally thought to exist 
merely as a deleterious byproduct of aerobic metabolism, that under normal (i.e., 
healthy) conditions were readily scavenged/degraded by the elaborate antioxidant 
defense machinery.  At any one time point, the actual oxidative burden imposed to the 
system is dictated by the net balance of these two opposing systems (H2O2/ROS 
production vs. antioxidant buffering).  In line with this notion, the term oxidative stress is 
commonly utilized as a general indication of any biological situation in which the 
production of H2O2 exceeds the ameliorating capabilities of the antioxidant defense 
system, potentially resulting in modification/ damage to various macromolecules (18).  
This definition vastly underestimates the complexity the cellular redox environment, as it 
has recently been demonstrated that the continual production of H2O2, at concentrations 
far below that indicative of “oxidative stress” is involved in the establishment of various 
redox signaling pathways, referred to as “redox circuits” (29).  Disruptions in this 
signaling network either via increased peroxide production and/or decreased NADPH 
availability are likely the primary consequences of “oxidative stress”, rather than the 
more classical idea of radical-mediated damage to macromolecules (28).  With respect 
to the continual source of H2O2 necessary for the establishment of redox circuitry, 
complex I and complex III within the ETS are commonly cited as the primary 
contributors in vivo (6, 52).  Generation of H2O2 from these sites however is highly 
dependent on mitochondrial membrane potential, thus creating doubt as to whether 
H2O2 production would still be possible under conditions of high ATP demand (e.g., 
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exercise).  The matrix soluble dehydrogenases (53), as well as the ETF (49) are 
intriguing sources, as at least a portion of the H2O2 generate at these sites appears to 
be independent of membrane potential.   
The results presented in Chapter II expand upon this work by demonstrating a 
role for PDH as a key H2O2-emitting site within skeletal muscle under physiological 
constraints (i.e., under ADP-stimulated conditions in the absence of respiratory 
inhibitors).  PDH-derived H2O2 was found to be responsive to matrix nutrient balance 
(e.g., NADH/NAD+) and redox buffering integrity, with the latter revealing a novel 
functional link between PDH and NNT (Figure 16).  In Chapter III we investigated the 
impact of NNT loss, specifically within the C57BL/6J strain, on skeletal muscle 
mitochondrial respiratory kinetics and redox homeostasis, as well as whole body energy 
expenditure.  Loss of functional NNT within the C57BL/6J mice was found to impair 
pyruvate-supported respiration, negatively shift mitochondrial membrane potential and 
dramatically increase H2O2 emitting potential within skeletal muscle mitochondria.  With 
respect to the latter, we hypothesize that these findings may help to explain the 
increased susceptibility to HFD-induced insulin resistance previously demonstrated in 
the C57BL/6J mice, as elevations in mitochondrial H2O2 emitting potential has 
previously been linked to the development of diet-induced insulin resistance (2).  While 
the effects observed specifically within skeletal muscle are certainly interesting, the 
consequences of NNT loss at the whole body level are perhaps more intriguing.  Whole 
body O2 consumption and energy expenditure were found to be decreased in C57BL/6J 
compared to C57BL/6N mice, despite no differences in RER, food intake or ambulatory 
activity.  While the dependence of NNT-supported NADPH production is well known to 
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depend on the establishment of an electrochemical proton gradient across the inner 
mitochondrial membrane, this is the first evidence demonstrating a significant 
contribution of NNT-mediated ∆p dissipation to resting energy expenditure.  We 
hypothesize that these findings may help to explain the obesity prone-phenotype of the 
C57BL/6J mice demonstrated herein as well as by other investigators.     
Future Directions 
The present findings are novel in that they establish both PDH and NNT as principle 
regulators of the matrix redox environment specifically within skeletal muscle.  The 
importance of the redox buffering network in regulating matrix redox status represents 
the potential for a paradigm shift within the field in which investigative focus begins to 
consider the impact of potential alterations in the activity of NADPH-producing enzymes 
to increasing overall peroxide burden during human disease.  With respect to NNT, gain 
and loss of function experiments carried out in a tissue-specific manner will reveal much 
needed information related to the role of NNT in regulating redox homeostasis in vivo.  
To this end, methodological advances within the field of redox biochemistry which allow 
for in vivo assessment of H2O2 production and NADPH generation will be of paramount 
importance to deciphering the role of altered redox homeostasis in human disease.   
 
 
 
 
 
 
 
 
Figure 16.  PDH-derived JH2O2 production is a function of E2 reducing pressure 
and the matrix redox environment.  The rate of H2O2 production from the PDH 
complex is principally determined by the redox status of the E2 bound lipoate residues, 
 77 
 
which based on the ratio of DHLA/LA set the reducing pressure within the complex.  E2 
subunits are depicted as hexagons within the figure labeled “PDH Complex” with bound 
lipoate residues extending from 3 of the 6 faces.  The redox pressure of a given E2 
subunit is colorimetrically depicted and ranges from red (total oxidation) to blue (total 
reduction), based on the redox state of its exposed thiols.  The gauge to right 
represents the average redox pressure within the complex and the corresponding rate 
of H2O2 production. H2O2 produced by the complex is buffered by the glutathione and 
thioredoxin redox systems, which derive NADPH from nicotinamide nucleotide 
transhydrogenase (NNT) in the presence of a functional electron transport system 
(ETS) and a NADH source.  The NADH needed for this reaction could in theory arise 
from the PDH reaction, thus allowing for the complex to buffer its own H2O2.  Panel A 
depicts the complex under low flux conditions (e.g., fasted state) in which pyruvate 
supply is minimal, redox pressure is low and antioxidant buffering capacity is high, thus 
resulting in low level H2O2 production and subsequent emission by the complex.  Panel 
B illustrates the impact of accelerated pyruvate flux (e.g., fed state) and a reductive shift 
in E2 redox pressure, all of which places an increased demand on the redox buffering 
network and promotes accelerated production of H2O2 from PDH.    
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